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Abstract
Scoring functions seek to compute in different ways protein-ligand binding energies by summing together
the individual pairwise atomic interaction energies observed in crystal structures between the protein
and the bound ligand. To date though, accurate prediction remains a big challenge since existing scoring
functions fail to reproduce known binding energies with a sufficient degree of accuracy and robustness.
To overcome this problem, we assign a discrete weighting to the individual atomic interaction to account
for entropic desolvation factors on ligand binding. We thereafter re-compute the revised scoring function
and test the output against multiple sets of data to examine the robustness of the heuristic weightings
used.
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At the dawn of more personalised medicine, there remains a pressing need to understand in greater detail
the effect of polymorphic variation and/or mutations in drug target and drug metabolising enzymes on
drug efficacy. This is particularly important in the anti-cancer field where it is well known that drug
target enzymes such as the epidermal growth factor receptor (EGFR) typically accumulate mutations
during disease progression and that these accumulated mutations can confer either drug resistance or,
paradoxically, drug sensitivity[Waters & MacLeod, 2003]. Today, however, the molecular cause of these
effects are still rarely understood in any detail, even after the event, and our ability to predict such
effects a priori remains in its infancy [Evans & McLeod, 2003]. In the absence of reliable computational
approaches to this problem, there is still a very real need for, and reliance on, experimentally-derived
quantitative thermodynamic data.
Purely experimental approaches to generate the requisite thermodynamic data on a multitude of protein-
drug interactions (including binding constants, inhibition constants, rate constants, etc.) are hampered
by the fact that few groups worldwide in industry or in academia - can handle the throughput of
quantitative assays required across potentially hundreds of clinically-relevant variants, even for just a
single target protein and a handful of drug-like molecules. There is therefore tremendous scope for the
development of novel computational approaches that can accurately predict protein-drug interaction
energies.
By way of example, if the binding affinities of a range of small molecule inhibitors (e.g. existing drugs
and new drug candidates) could be accurately predicted across a range of clinically-relevant variants of
the intended drug target, this information could then underpin drug differentiation data that, together
with patient genotype, could be used by clinicians to inform the choice of the best drug for the specific
drug target variant present in the individual patient [Society, 2005] i.e. personalised medicine!
Computational approaches to this problem are usually described as ”scoring functions”, of which a
number are described in the literature and are available either as open source or commercial software
packages [e.g. X-Score[Wang et al., 1998] ]. Essentially, scoring functions aim to compute in different
ways the sum of the pairwise atomic interaction energies between a protein and a bound ligand; it is
clear though that the existing scoring functions are not yet able to predict binding energies with sufficient
accuracy or robustness.
In particular, the performance of typical scoring functions is limited in part by the simplistic assumption
that pairwise atomic interactions are independent and in part by their reliance on Newtonian mechan-
ics. In reality, protein-ligand molecular interactions are typically co-operative in nature, occur at the
atomic level, and also involve significant solvation effects so can only really be modeled efficiently using
quantum mechanics (QM). However, the computational resources required for such QM calculations on
the thermodynamics of protein-ligand interactions are machine intensive and, whilst QM-based scoring
functions represent a promising avenue for future research, they are not considered further here.
Taking EGFR kinase - a validated drug target in Non Small Cell Lung Cancer (NSCLC) as a case in
point, the experimentally-derived in vitro inhibition constants of a number of EGFR kinase variants have
been shown elsewhere to correlate reasonably well with patient survival in the clinic. For example, the
in vitro inhibition by Iressa of the L858R variant, the G719S variant and the wild-type (Wt) EGFR
enzyme follows the trend L858R > G719S > Wt, whilst clinical survival of patients having these
1
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variants follows the same trend [[Paez, 2004], [Yun et al., 2007]]. However, despite the existence of
this experimental data on drug binding constants, preliminary calculations have shown that existing
generalist scoring functions, such as X-Score, fail to accurately compute the binding affinity of drugs
such as Gefitinib (aka Iressa), Erlotinib (aka Tarceva), Lapatinib etc. in their in vitro inhibition of
the L858R, G719S or Wt variants of EGFR kinase and even struggle to get the rank order of ligand
binding strength. By extrapolation, there seems to be little prospect that such existing generalist scoring
functions could currently accurately compute and rank the binding affinities of even this limited set of
existing drugs against the >100 known clinical variants of EGFR for which experimental data is not yet
known.
The present work therefore seeks to develop a novel heuristic computational approach to solve this
problem, with the aim of creating an accurately predictive computational model of interaction affinities
between protein kinase variants and drug-like molecules.
In particular, the hypothesis explored in this Thesis is that, by assigning heuristic weightings to individual
pairwise atomic interactions, it may be possible to effectively allow for differential desolvation factors
that affect protein-ligand interactions and which are currently not accounted for in scoring functions such
as X-Score, thereby obtaining a better and more robust correlation between computed and experimental
binding energies. The case study used to explore this hypothesis here is based on the performance of
the X-Score scoring function on protein kinases; the results and discussion will focus thereafter on the
sensitivity and re-parameterisation of X-Score.
2. Overview of Scoring functions
2.1 Introduction
In Medicinal Chemistry, the likely potency of a drug candidate is often assessed initially by its association
constant with the protein receptor, which is in turn related to the free energy of binding. There are
currently a number of ways to estimate this value computationally of which the most physically realistic
are techniques involving methods such as molecular dynamics (MD) or Monte Carlo (MC) simulation,
and statistical mechanics tools such as free energy perturbation (FEP) [Kollman, 1993] that extracts
the relevant information from the simulation trajectories. However, these methods are very complex
and computationally expensive and, even with the modern availability to cheap super computing power,
require running times in the order of days per ligand.
Docking programs use scoring functions to return the predicted free energy of each identified three
dimensional structure by estimating the interaction energy between ligand and receptor. A docking
program uses scoring functions in two phases. The first phase tries to identify the true mode of binding
for the ligand; To achieve this each molecule is associated with an ensemble of conformations and these
are then posed inside the receptor in different orientations. The energy returned by scoring function is
kept if the score is good and dropped if it is not. In the second phase, poses are now ranked according
to their computed scores. The scoring functions used to find the various orientation and to rank the
poses are not necessarily the same. To obtain a correct ranking that correlates with experimental
free energies of binding, a more elaborate scoring functions is required to identify the true binding
mode [Jhoti & Leach, 2007].
2.2 Parameters in scoring functions
The components required for scoring functions can be developed by considering the fundamental physics
of intermolecular interactions. The accurate evaluation of electrostatic interactions is one of the hurdles
in binding free energy and is modeled using the Coulomb’s law. Hydrogen bonds are still assessed by
electrostatic interactions between an electronegative atom (acceptor) and a hydrogen atom covalently
bound to another electronegative atom (donor). Hydrogen bonding gives some specificity to the binding
process because all hydrogen bonding sites in a protein-ligand complex should be satisfied for optimum
binding to be observed[Bohm & Klebe, 1996]. Van der Waals interactions are also another major con-
tributing factor to interaction energies and parameterise the interaction between nonpolar molecules,
giving balance between attractive and dispersion forces [ [Atkins, 1998], [Ajay & Murcko, 1995]]. This
hydrophobic effect explains the preferential association between non-polar molecules, or an area of
molecules, to minimize water contact. The above list of parameters in scoring functions is far from
exhaustive since the calculation of free energy of binding is not fully understood yet. Moreover, the
above parameters only attempt to describe the enthalpic component of a ligand binding event, not
the enthropic component which is itself to be at least as important (according to the second law of
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3. vibrational entropy.
Of these, translational and rotational entropy are the biggest factors in ligand binding but are difficult
to accurately compute for large molecules.
2.2.1 Binding Affinity






where R is the receptor, L the ligand, RL product or the complex, k−1 is the association rate constant
for the reaction going from right to left, and k+1 is the dissociation rate constant for the reaction going
from left to right [Ajay & Murcko, 1995].





where Kd is the equilibrium constant used for expressing binding affinity and is usually referred to as
the dissociation constant. When the value of Kd is small, the tendency of RL to dissociate is small,
i.e., RL tends to remain as a complex.
The thermodynamic equation that relates the free energy change to change in enthalpy and entropy is
given by the equation,
∆G = ∆H − T∆S (2.3)
where ∆G denotes the change in free energy of reaction, ∆H and ∆S are the corresponding changes
in enthalpy and entropy, and T is the temperature of the system. The equilibrium constant is related
to the free energy change [Ajay & Murcko, 1995] of the dissociation of RL as,
∆G = ∆G◦ +RT lnKd (2.4)
Where, R is the gas constant, and T is the absolute temperature. ∆G◦ is free energy change associated
with the reaction under standard conditions. At equilibrium ∆G = 0, so that we have,
∆G◦ = −RT lnKd (2.5)
The Kd for model system is only a function of temperature, this is why it is therefore called the
equilibrium constant.
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2.2.2 Binding constant, dissociation constant and IC50
The inhibition constant Ki is measured in kinetic experiments where both the substrate and the inhibitor
are present, but not necessarily at equilibrium unless steady state kinetics is assumed. More direct Ki
measurements (usually called a Kd measurement) that do not involve competition with substrate are
equilibrium measurements. All comparison with experimental data should therefore take place when the
experiments are performed under equilibrium conditions [Ajay & Murcko, 1995].
The interaction of ligand with a protein may also be measured in terms of the IC50 value. The IC50
represents the concentration of a drug or inhibitor that is required to reduce the binding of a ligand
(or rate of reaction) by half. In theory Ki or Kd is preferred to IC50 because IC50 depends on the
amount of ligand available to the receptor and therefore the comparison of data obtained under different
conditions is impossible. The binding constants Ki or Kd can be compared more easily. In principle, for
any inhibitor Ki = Kd. Determination of binding constants require more data than is needed for IC50.
The IC50 is then defined as the concentration of ligand at which 50% of the receptor sites are occupied
in one to one complex. As a result, IC50 values are not true inhibition constants. Another measure
associated with drug potency is EC50 or half maximum effective. It is the concentration of a drug,
antibody or toxicant required to obtaining 50% of the maximum effect after some specified exposure
time. Like IC50values, EC50 values are therefore not true inhibition constants [Ajay & Murcko, 1995].
2.2.3 Thermodynamics of Binding
The difference in free energy between the bound and the free states is the quantity of interest for
determining the binding constants, given by
∆G = Gc −Gu (2.6)
The superscript ”c” and ”u” are for complexed and uncomplexed, respectively. So, Gc and Gu means
the total free energy of all interactions in bound (i.e complex) and unbound or free states respectively.
As stated previously, the calculation of free energy of binding is not an exact science yet and different
approaches to scoring have led to different kinds of scoring functions. They are usually classified in
a tree-like structure, with three principal branches, plus one ”hybrid” type. The three principle types
force-field, empirical, and knowledge-based scoring functions as well as the ”hybride type”, consensus
scoring will be discussed below [Halperin et al., 2002].
2.3 Force Field scoring functions
This class of scoring function uses the molecular force fields where the vibrational potential energy of a






Where k is similar for similar bonds ( C - C, C - N, C - S, etc.). Force fields are used to provide this
information.
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Among the parameters used to develop force fields are bond stretching, valence angle bending, torsional
angles, Van der Waals interactions and electrostatic interactions. The force fields also take into account
the desolvation effect and the action of water as a solvant [Shoichet et al., 1999] using either a distance
dependent dielectric constant [Vieth et al., 1998] or a complete Poisson-Boltzmann treatment. The
computation of Poisson-Boltzmann term is very expensive so it is typically substituted by other faster
approaches like the generalized-Born model(GB/SA). Usually the algorithm used takes approximately
10 seconds per orientation on a silicon graphic R10000 computer [Zou et al., 1999].
The force field scoring functions also take into account the internal conformational energy of the
ligand. It is generally accepted that when a ligand binds inside a binding site, it will do so in a
low energy conformation [Bostrom et al., 1998]. The components of the Amber [Cornell et al., 1995],
Charm[Brooks et al., 1983] and MMFF(Merck Molecular FF) [Halgren, 1996] are used as scoring func-
tions in many docking programs.
In recent year Pearlman and Clarifson introduced a new approach to force field scoring [Pearlman, 1999]
[Pearlman & Charifson, 2001] in which they developed and tested OWFEG (One-Window Free Energy
Grid), which is a grid approximation of the free-energy perturbation method. In OWFEG, a short
Molecular Dynamics (MD) simulation is used to build a grid of free energy values relatives to some
probes (neutral, charged, methyl) around the active site. The score is obtained by linear interpolation of
these values for a given docked pose and Ki value can be predicted [Pearlman, 1999] using this method.
2.3.1 Problems and solutions
The main drawback with force-field scoring functions is that their computation is quite time consum-
ing. Furthermore, parameters that are initially derived for other simulation methods, such as MD
or Monte Carlo (MC) calculations, may not be suited for single-point energy estimates; correlations
with experimental data may be poor, especially when the ranked compound does not belong to the
same class. Poor charge modeling also seems to have a detrimental effect. The obvious solution
to these problems seems to be the development of potentials and charge models for specific use in
scoring functions. Another remedy could be the introduction of new non-bonded terms to estimate
interactions that until now have been neglected or merged with others [Fenu et al., 2007]. As an ex-
ample[ [Raha, 2005] [Raha & Merz, 2005] [Raha & Merz, 2004a] [Raha & Merz, 2004b] ] we can cite
a quantum-mechanically-based semi-empirical Hamiltonian approach to scoring functions used to esti-
mate the metal-ligand interaction contribution to free energy of binding. Although currently too slow
for virtual screening, there is clear opportunity for such methods to be more widely used if they provide
information that simpler scoring functions cannot.
2.4 Empirical Scoring functions
Another class of scoring functions is the empirical scoring functions. The idea behind these scoring
functions is that the free energy of binding is split into series of terms, each of which has a specific
and intuitive explanation. It turns out however that the assumption of decomposing the free energy of
binding into different components is not accurate because the free energy of binding is a function of
state whereas the energy components into which it may be divided are not [Mark & Gusteren, 1994].
Empirical Scoring functions do lead however to an interesting approximation that proves to be useful
to some extent. The computational approach to calculation of these terms is typically relatively simple
and many terms can therefore be used and implemented in different ways. Such empirical scoring
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methods are used for example in structure-based virtual screening (SVS). The first attempt at empirical
scoring involved the building of a knowledge base from the analysis of group-to-group interaction in 200
complexes with known experimental binding affinity [Andrews et al., 1984]. These methods do not use
the three-dimensional structure of the complex, as they simply count the number of interactions that
were presumed to exist in the complexes used as reference.
Later, atom-to-atom approaches were introduced, with the knowledge of the three-dimensional structures
of the training set leading to a greater level of detail in the analysis of interactions between receptor
and ligand [Bohm & Klebe, 1996]. The mathematical expression of the free energy of binding is given
as a sum of interaction terms, each multiplied by its own weight or coefficient. The formula is written
as :
∆G = Σifi∆Gi (2.8)
Where, fi are the coefficients, and ∆Gi are the free energies associated with each term, each term
reflecting an interaction involved in the binding process. Other non-linear functional forms have been
investigated [Giordanetto et al., 2004], but results do not seem to be very conclusive as non-linear terms
do not sufficiently improve predictive power to justify the computational overhead and loss of physical
meaning on moving away from familiar terms. Coefficients are generally obtained through optimisa-
tion/regression techniques in which the scores given by an equation are fitted to known experimental
binding affinities. The work by Smith et al. [Smith et al., 2003] provides a different approach where the
scoring function is instead parameterised using enrichment of true binders interspersed among a number
of decoy molecules.
2.4.1 Parameters in empirical scoring functions
Common terms in empirical scoring functions include those for hydrogen bonds, ionic interactions,
hydrophobic interactions, and the internal energy of the ligand. The parameters in empirical scoring
functions are similar to non-bonded force field potentials where parameters are provided by fitting
score to known experimental binding affinities. Because of the additive feature of empirical scoring
functions, larger ligands tend to score better than small ones. However, larger ligands suffer from the
fact that on binding, more degrees of freedom are frozen by confinement in the receptor pocket and the
consequential the entropy change usually disfavours binding. Terms that try to estimate this entropy
change, predominantly through rotatable bond counts or similar quick methods, are therefore typically
added. Another approach to account for ligand size is to scale the scores obtained, for example Pan et
al. suggested multiplying the score by the square root of the number of heavy atoms, or the ligand’s
molecular weight [Pan et al., 2003], but this seems a rather crude and overly simplistic approach and is
not widely used.
2.4.2 Problems and Solutions
Despite their success in modeling some complex interactions with relatively simple equations, empiri-
cal scoring functions have their limitations. A major drawback of any regression-based scoring func-
tion is the dependence on the size, composition and generality of the training set used to derive the
weights [Fenu et al., 2007]. To counter this, efforts are being made to create common training and
validation sets, containing diverse proteins and ligands. Another common approach is to build scoring
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functions ’tailored’ for a certain class of protein or ligand [Bohm, 1994]. A further problem with em-
pirical scoring functions is that they, like force field scoring functions, often lack terms to account for
some interactions. For example, metal-ion interactions are often neglected or approximated by simple
coulombic terms, without any reference to charge transfer and coordination. Unfortunately, gathering
sufficient information to parameterise such terms can be difficult, so their contribution to the binding
is often merged into other terms which can create obvious problems.. For example, if metal ion inter-
actions are neglected and we do not have proteins that use metal to bind the ligand in our training set,
then the scoring function will obviously fail when applied to such a protein. Alternatively, if we have a
few cases in our training set, but no term to account for metal binding, then regression analysis may
try to compensate by increasing the factor for the coulombic interaction and even in the case of metal-
proteins, this function would not behave correctly, as a modest over estimation would not be sufficient
to address the missing metal ion term. The answer, in this case, is to develop and add new terms and
once again to select accurately the training set to reflect the application field. Another problem inherent
in the empirical scoring function approach is that the training sets used to drive such functions usually
do not contain ”negative” data (i.e unfavourable inter- or intra- molecular interactions) since these are
very rarely observed in X-ray structures. Finally, it is of the utmost importance to remember that these
models are just that, and as such will always be limited in scope and applicability [Fenu et al., 2007].
2.4.3 Some Advances
A number of novel empirical scoring functions have appeared recently some of which are simple re-
editions of earlier functions. For example, Verdonk et al. [Verdonk et al., 2003] re-implemented Chem-
Score [Eldridge et al., 1997] within GOLD [Jones et al., 1997] and conducted studies on the influence
of using different scoring functions for the sampling and ranking parts of the docking process using the
CCDC/Astex docking test set divided into fragment-like and drug-like ligands. Overall, this study con-
firmed that using GoldScore for both sampling and ranking yields more accurate results; this is in contrast
with previous assumptions that using two different scoring functions for the two docking phases would
improve the quality of the poses (for example, using ChemScore for sampling and the outcomes (results)
being re-ranked with Goldscore). Verdonk et al [Verdonk et al., 2003], allowed for water molecules to
be switched on and off at their experimentally determined position during docking; GOLD’s GoldScore
and ChemScore functions were then modified to consider the loss of water’s rigid body entropy upon
binding, with a constant penalty term σp, obtained from a training set of 58 complexes, and tested
against 225 complexes. The method managed to correctly predict water displacement/mediation for
over 90% of the complexes in both training and test sets.
Mancera et al. [Mancera et al., 2004], in their program EasyDock [Todorov et al., 2002], used PLP
[Gehlhaar et al., 1995] to carry out sampling, and ScreenScore, which put together the functionality of
PLP and FlexX’s own score, to re-rank the results [Stahl & Rarey, 2001]. The program GEMDOCK,
[Yang & Chen, 2001] uses a generic evolutionary method for docking and a novel empirical scoring
function built with three terms: coulombic interactions with simplified charges; PLP-like hydrogen bond
terms; and internal energy [Fenu et al., 2007]. This final term is in fact a constant penalty to maintain
poses to a pre-defined docking box. The program has been tested for binding-mode recognition against
100 protein/ligand complexes selected from the Protein Data Bank (PDB), the results of which show
that in 79% of these complexes, the docked lowest energy ligand structures had root-mean-square
deviations (RMSDs) less than 2.0Å with respect to the corresponding crystal structures. The success
rate increased to 85% if the structure water molecules were retained. GEMDOCK was evaluated on
two cross-docking experiment in which each ligand of the set of protein was docked into each protein
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of the group. 76% of the docked structures had RMSDs below 2.0Å when the ligands were docked
into foreign structures. The analysis and validation from GEMDOCK performance with respect to
various search spaces and scoring functions, shows that the outcome is function of the quality of scoring
function, if the degree of accuracy of the scoring function used is high , then the predicted accuracy
from GEMDOCK will also be high. The authors then conclude from their finding that GEMDOCK is
a useful tool for molecular recognition and may be used to systematically evaluate and improve scoring
functions [Stahl & Rarey, 2001].
A new version of GLIDE has also been described [ [Friesner et al., 2004] [Halgren et al., 2004] which
uses a series of filters of increasing complexity to select good binding modes and includes a scoring
function derived from ChemScore [Eldridge et al., 1997], extended with a few more terms. According
to the authors the overall performance of GLIDE is equal or superior to those of GOLD and FlexX.
An opportunity to improve the performance of scoring functions lies in the method by which a function is
parametrised. Smith et al. [Smith et al., 2003] have built a novel scoring function by selecting terms from
Gschwend’s TEC toolkit containing a variety of 2 and 3-D descriptors for protein-ligands interactions.
The novelty of the method does not lie in the terms selected like hydrogen bonds, coulombic interaction,
a contact/clash count, and buried hydrophobic surfaces term; but instead the parametrisation method
attempts to mimic a Structure-based Virtual Screening (SVS) experiment, with a training set of twenty
proteins and 1000 ligands selected from the World Drug Index (WDI). The ligands were used as decoy
to hide the known ligand, while a genetic algorithm adjusted the parameters to optimise the enrichment
factors. The genetic algorithm (GA) is an optimization and search technique based on the principles of
genetics and natural selection. A GA allows a population composed of many individuals to evolve under
specified selection rule to a state that maximizes the fitness [Haupt & Haupt, 2004].
2.5 Knowledge-based scoring functions
This class of scoring functions has been developed, thanks to the huge increase in crystal structure with
high resolution obtained by X-ray diffraction, solid state NMR and a number of other related methods.
The fundamental idea of a knowledge-based scoring function is to extract statistical information about
the ligand/protein binding modes and to correlate these to free energy of binding using statistical
mechanics. Knowledge based pseudo-potentials are usually derived by accumulating radial distribution
functions for selected pairs of protein-ligand atoms. The inverse formulation of the Boltzmann equation,
or a derivative thereof, is then used to extract the corresponding potentials of mean force from these
distributions. To apply these potentials to scoring, the distances between the protein and ligand atoms
in each pose is calculated and the total score is obtained by summing each of the energies derived from
the potential curves using these distances [Fenu et al., 2007]. The Boltzmann equation can be written
as:
Eij = −kT ln ρij(r)− kT lnZ (2.9)
Where, Eij is the interactions energy involving atom i on the protein and atom j on the ligand; ρij
is the radial distribution function between the two atom-types at distance r and Z refers to partition
function. The fact that no particular function has been imposed to form the pseudo-potential curves,
it is implicitly accepted that any possible kind of interaction could occur, irrespective of whether it is
enthalpic or entropic [Fenu et al., 2007].
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It must also be noted that besides the functional form used to derive the potentials from the populations,
the differences between various incarnations of knowledge based functions lie in the amount of data used
for parametrisation and in the number of atom types considered. It has been suggested that the more
protein-ligand complexes used in parameterisation, the better as higher quality statistical information
can be extracted from a larger knowledge-base. This consideration is also relevant to the the diversity of
the chosen parameterisation set, which will produce a much more robust scoring function. On the other
hand, increasing the number of atom types, does not necessarily build a better potential: Add too many
and the data becomes fragmented because there may not be sufficient information to build pseudo-
potential curves between certain atom pairs, with the data effectively being wasted plus there being a
risk of over-fitting the function. Conversely, if there are insufficient atom-types, different interactions
will be incorrectly grouped, giving potential curves that, although smoother, may have unphysical
features: For example, a single pseudo potential curve with two minima could arise from superposition
of two single-minima curves. Alternatively, it may signify the presence of some angular-dependent
phenomena, which radially-symmetric potentials cannot incorporate effectively [Fenu et al., 2007]. Good
practice is arguably to choose well-known and well-defined atom-types, as Gohlke and coworkers did with
DrugScore [Gohlke et al., 2000], which uses 17 atom-types taken from the Sybyl mol2 format. This
appear to be a good choice as it reduces the difficulties of reliable ligand atom-typing. Others such as
Muegge and Martin [Muegge & Martin, 1999] extract a potential with more than 17 atom types used
to represent the diversity of pairwise interaction in their parametrisation set, or adopted custom-defined
atom. In the improved Potential Mean Force (PMF) scoring function [Muegge & Martin, 1999], they
choose atom-types based on chemical features and not the atom’s hybridisation state.
The first applications of knowledge-based scoring functions to drug design were strictly focused on
HIV protease [ [Mizutani et al., 1994], [Verkhivker et al., 1995] ] the only proteins at the time for
which there were sufficient structural data to develop a scoring function. The outcomes was promis-
ing, the early attempts did not return a generally applicable function. Among other programs util-
ising a knowledge-based pseudo-potential, we can cite are SMoG [ [DeWitte & Shakhnovich, 1996],
[DeWitte et al., 1997] and BLEEP [Mitchell et al., 1999] . In the latter, functional form for the shell
density is different, and the knowledge-based function is complemented by a Van der Waals term to
compensate for the low occurrence of short range interactions in crystals. The PMF scoring func-
tion [Muegge & Martin, 1999] also contains a volume correction factor, to account for the volume
around each ligand atom occupied by other ligand atoms. This function was tested against the FKBP
protein [Muegge & Martin, 1999] and it was modified to improve virtual screening performance by sub-
stituting the knowledge-based curves with Van der Waals terms to account for short-range steric effects
otherwise neglected. In DrugScore [Gohlke et al., 2000], a knowledge-based one-body potential, scaled
to the size of the solvent-accessible surface (SAS) of the protein and the ligand that becomes buried
upon complex formation, was added to PMF-like pairwise pseudo-potentials. This results in DrugScore
effectively being a mixed knowledge/empirical scoring function. Ishchenko et al. released a new version
[Ishchenko & Shakhnovich, 2001] of SMoG (SMoG2001), parametrised on 725 structures, and tested
against 119, reporting performance similar to DrugScore and better than PMF and SCORE1 (LUDI
[Bohm, 1994], the improvement being mainly attributed to a better description of the reference state
used to normalise the radial distribution function.
The biggest drawback of knowledge-based scoring functions, apart from doubts about their statistical-
mechanical meaningfulness, is that not all interactions can be approximated efficiently by pairwise
terms. Moreover, many interactions are highly directional, whereas radial distribution function-derived
pseudo-potentials have spherical symmetry. Although a certain degree of directionality comes from the
interplay of different pairwise interactions, the issue has not yet been fully addressed. Despite this
limitation, these functions are cheap to evaluate and work reasonably well within the lead-identification
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phase of drug-design. With the constant increase in the number of resolved protein structures, the
reliability and general applicability of these functions is likely to improve, and the possibility (re-)opens
for functions to be optimised on certain protein-ligand classes, or even for different alternative non-
pairwise representations of the intermolecular interactions [Fenu et al., 2007].
2.6 Consensus scoring
Since none of the scoring function classes presented above is clearly superior to others, a more pragmatic
approach to obtain good results is to combine their separate judgments. This approach, called ”consen-
sus scoring”, was pioneered by Charifson et al [Charifson et al., 1999]; two or more scoring functions are
applied to the same set of poses and only structures that perform well in more than a pre-defined share
of the said scoring functions are retained. Consensus scoring, analyzed in detail by Wang and Wang
[Wang & Wang, 2001.], is effective in reducing the number of false positives, which may be able to trick
one function, but not all, into believing they are actives. For this reason, performance is particularly good
when functions included in the consensus are different, in the sense that they describe different aspects
of binding. For example, a scoring function oriented towards the careful detection of hydrogen bonds
will complement a more hydrophobic function, whereas the union with a more similar function may not
be so productive. An example of consensus scoring function is ScreenScore [Stahl & Rarey, 2001], built
from the consensus of PLP and FlexX. In many cases however, the description of the protein-ligand
interactions is still deficient, so there remains room for new terms to be added.
2.6.1 Recent Advances
The consensus scoring field has been very active recently, with a number of interesting papers exploring
new solutions and extending and/or confirming other researchers’ ideas and suggestions. Verdonk et
al [Verdonk et al., 2003] tested a number of different consensus combinations and confirmed Wang’s
insight that rank-by-number outperforms rank-by-rank and rank-by-vote strategies in consensus scor-
ing. Wang [Wan, n.d.] and colleagues again, using three scoring functions built upon their previous
work (SCORE [Wang et al., 1998]), creating a new consensus scoring method (X-SCORE) which was
calibrated to reproduce the binding affinities of 200 complexes, and tested against thirty more.
Guo et al. [Guo et al., 2004] built a consensus scoring function within Sybyl consisting of ChemScore,
G-Score, F-Score, PMF-score and DrugScore. These five were combined using multi-linear regression.
The training set here consisted of 53 inhibitors of Torpedo Californica AChE from PDB entries with
known affinity re-docked into a human AChE and 16 compounds were used as a test set.
In the same fashion, Jacobsson [Jacobsson et al., 2003] applied a number of different training methods
to ’multidimensional’ consensus scoring with partial least squares, discriminant analysis, Bayesian clas-
sification, and rule-based methods being applied to improve discrimination between active and inactive
compounds.
Klon et al. [Klon et al., 2004] used a naive Bayesian machine-learning algorithm to improve enrich-
ment in high-throughput docking of databases by selecting the important features from the top ranked
structures with extended connectivity fingerprints and correlating these to their high-scoring compounds.
This method works by re-ranking the docking outcome and retrieving compounds similar to those at/or
near the top of the list from the remainder.
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2.7 Comparisons between scoring functions
There is a growing interest in comparing different scoring function head to head to identify common
deficiencies and improve scoring methods. There are a number of recent papers that tackle this issue
from different view points. Wang et al. [Wang et al., 1998] tested 11 freely and commercially available
scoring functions by reproducing the affinity of 100 protein-ligand complexes. Later, the same authors
extended the test, by using 14 different scoring functions and binding affinities of 800 complexes from
the PDBBind [Wang et al., 2004] database. Ferrara et al. [Ferara et al., 2004] assessed 9 scoring
functions for their ability to recognize the correct ligand orientation in 189 complexes from LigandPDB
[Roche et al., 2001]. Krovat et al. [Krovat & Langer, 2004] applied LigandFit to the test case of renin
: 10 inhibitors were mixed with 990 drug-like compounds, docked and then analysed with seven scoring
functions: LigScore1, LigScore2, PLP1, PLP2, JAIN, PMF, LUDI. The consensus combination PLP1 +
PLP2 + PMF performed the best, presenting all known inhibitors within the top 8%.
In another insightful study Kontoyianni et al. investigated the sensitivity of five docking programs
(FlexX, GOLD, DOCK, LigandFit, GLIDE) to the nature of the active site. 69 receptors (belonging
to 14 families) were used as targets. Their findings show that GOLD, followed by Glide, perform well
in predicting accurate poses. In the same fashion, Perola et al. [Perola et al., 2004] compares three
docking programs GLIDE, GOLD and ICM, to identify correct binding mode using a mixed test set
of Vertex in house complexes and complexes from PDB data bank. The objective of the study was
to assess how the nature of active site is influenced and what is the effect of energy minimization on
scoring. Glide was able to correctly identified the crystallographic pose within 2.0Å in 61% of the cases,
against 48% for GOLD and 45% for ICM. In most of the case the performance of the Glide appears
to be consistent with respect to diversity of binding sites and ligand flexibility, while the performance
of ICM and GOLD is likely dependent on the binding site and it is significantly poorer when binding
is done mainly by hydrophobic interactions. The findings also show that energy minimization and re-
ranking of the top N poses can be an effective means to overcome some of the limitations of a given
docking function. Another test compares these three programs on HIV-1 protease, p38 MAP Kinase
and IMPDH, which reveals that the performance of GLIDE is better than the other two programs on
these target. DOCK, FlexX, GLIDE, GOLD, Slide, Surflex, and QXP have been tested by Kellenberger
et al. [Kellenberge et al., 2004] in a 100 X-ray small-ligand structure reproduction and simulated SVS
experiment. As result of the test GOLD, GLIDE, and Surflex did well at both tasks, but the performance
of the docking programs was subject to criticism by the authors on the basis of their active features,
and the common failures that were identified. In Vigers et al. [Vigers & Rizzi, 2004], once again, these
studies show that FlexX and Gold are able to correctly select the right ligand orientation, but fail to
consistently rank a series of ligands. A statistical multiples active correction (MASC) was presented
which reduces for ligands that are found to score well not only with the target of interest, but also with
another selected set of seven to nine diverse protein structures. This correction was shown to improve
ranking, but unfortunately it is specific to the docking and scoring algorithm used, and so must be
re-generated for any new combination [Fenu et al., 2007].
2.8 New Test and Training Sets
Many scoring functions have been calibrated with different data sets making the comparison between
functions difficult. As a result of this, the notion of having a common training set for all functions has
been suggested by researchers in the field. It is generally recommended that the training sets should
Section 2.9. Summary Page 13
include many diverse proteins so it is representative of the ’protein space’. The ligands to which the
protein are complexed should also be diverse and arguably should all be drug-like [Lipinski et al., 2001].
Numerous attempts have been made to provide standard training and test sets, the most comprehensive
contribution to date coming from PDBbind by Wang et al. [Wang et al., 2004]. The new version of
PDBbind, released in 2012, provides binding affinity data for a total of 9308 biomolecular complexes
in the PDB, including protein-ligand (7121), nucleic acid-ligand (79), protein-nucleic acid (511), and
protein-protein complexes (1597). The Mother of all Data Base (MOAD) or Binding MOAD, whose
goal is to provide the largest collection of well resolved protein crystal structures (2.5 Å or better) with
experimentally determined binding data extracted from literature, currently contains 18,764 Protein-
Ligand structures; 6,311 structures with Binding Data; 9,048 different ligands [Hu et al., 2005]. The
BindingDB [Liu et al., n.d.] is another source of measured binding affinities containing 910,836 binding
data for 6,263 protein targets and 378,980 small molecules.
In this effort to standardize the data sets there is still challenge of reliable experimental data among
which we can list :
1. Different databases report different values forKi/Kd/Kn/IC50 for the same complexes,
2. This reflect the fact that different labs use different experimental methods and different models
to generate and interpret binding data,
3. All of these of course impact strongly on the performance of any empirical scoring function, as
well as on the assessment of relative performance of all scoring function.
2.9 Summary
In this Chapter, a broad review of the scoring functions in the context of docking small molecules to
protein targets has been presented. The basics of scoring functions have been presented as well as
the recent advances in each three classes of scoring functions. We also discussed consensus scoring,
comparisons between scoring functions and finally the collection of structural data with the specific
purpose of scoring function testing. Our next Chapter focuses on X-Score, one of the best performing
empirical scoring functions integrated into the molecular design tool kit for drug discovery and docking.
2.10 Problem statement
Many workers in the field of Medicinal Chemistry have appreciated the limited ability of existing scoring
functions to distinguish correctly between protein-ligand binding strengths and a number such groups
are tackling this problem through the use of more sophisticated free energy calculations.
However, in our opinion the weakness of existing scoring functions is only in part on their reliance on
Newtonian mechanics to calculate the pairwise atomic interaction energies; instead, we believe that
their major weakness lies in their failure to allow for the entropic factors arising from desolvation effects
and protein conformational changes on ligand binding. Free energy calculations, which try to address
these issues are however very complex and computationally expensive. We therefore seek to develop a
simpler method that addresses these limitations.
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In other words, we believe that the underlying cause for the failure of existing generalist scoring functions
to recapitulate experimentally-determined protein-ligand binding trends is because they fundamentally
assume that the enthalpic component of the protein-ligand interaction in the ligand-bound state domi-
nates the binding affinity and because they also assume that the amino acid residues of the target proteins
make equal contributions to drug-target binding strength, both of which are limiting assumptions.
We therefore propose to take a different, heuristic approach to the problem, based not on revamping the
pairwise atomic interaction energy calculations themselves, but by assigning weightings to the individual
pairwise atomic interactions. Thereafter, we re-compute the revised scoring function and test the output
against real experimental data to examine the robustness of the weightings used.
2.11 Aim of thesis
The aim of this thesis were :
1. To test the sensitivity of the X-Score scoring function with the kinase/protein family.
2. To evaluate the performance of the differential weighting on hydrogen-bonding in interactions in




X-Score is a general empirical scoring function for estimating the binding affinity of a protein-ligand
complex. It has major potential for application in structure-based drug design studies. There are three
individual empirical scoring functions implemented in X-Score, which are named as HPScore, HMScore
and HSScore, respectively. They can be conceptually summarized [Wang et al., 1998] as:
HPScore = C0,1 + CV DW,1 × (V DW ) + CHB,1 × (H −Bond) + CHP × (HP ) + CR,1 × (Rotor)
(3.1)
HMScore = C0,2 + CV DW,2 × (V DW ) + CHB,2 × (H −Bond) + CHM × (HM) + CR,2 × (Rotor)
(3.2)
HSScore = C0,3 + CV DW,3 × (V DW ) + CHB,3 × (H −Bond) + CHS × (HS) + CR,3 × (Rotor)
(3.3)
Here VDW, H-Bond, HP, HS account for Van der Waals contacts, Hydrogen Bonding, Hydrophobic
Pair, Hydrophobic Match, Hydrophobic Surface respectively upon the binding process. The constants
C0,i, CV DW,i, CHB,i , CR,i with i = 1, 2, 3 and CHP , CHM and CHM are coefficients of different terms
that were obtained from the three linear equation above through regressional analusis on a training set
composed of 200 protein-ligand complexes. The goal for developing X-Score was [Wang et al., 1998]:
1. Have a fast, accurate and robust scoring function for structure based drug design;
2. Provide a practical tool to interpret the interaction between a ligand and its target protein.
The underlying idea in the X-Score method is that binding affinity is decomposed into the contribu-
tion of individual atoms. Each atom in a ligand has what is called an atomic score, indicating its
role in the binding process. This major innovation of atomic binding allows those who work in drug
discovery, for example, to inspect and optimize the lead compound structure in a more rational way
[Wang et al., 1998]. Below, we describe the method or algorithm used to compute each term in the
function.
3.2 Methods and Algorithm
3.2.1 Training set
X-Score was calibrated with a training set comprised of 170 protein-ligand complexes. All the complexes
came from the PDB (Protein Data Bank)archive and the data included more than 17 different proteins
types, with end structure having a resolution better than 3.2 Å (Ångtröm), making X-Score a generalist
scoring function. All the experimental binding was taken from literature and expressed as the negative
logarithm of dissociation equilibrium constants, pKd [Wang et al., 1998].
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The authors of X-Score used the SYBYL software to prepare the receptor and ligand for analysis. To do
so, the first extracted the ligand from the complex structure and assigned proper atom type and bond
type to the ligand in a new mol2 file. The protein was written to a separate file in PDB format; any
molecules such as water molecule, metal ions, and other co-factor were treated as part of the protein.
Protons were also added to the protein and ligand [Wang et al., 1998].
3.2.2 X-Score Scoring Function Algorithm
The empirical scoring functions are built on the principle that the free energy change in the protein-
ligand binding process can be dissected into basic components. The function equation in X-Score takes
the following form :
4G = 4Gvdw +4GH−bond +4Gdeformation +4Ghydrophobic +4G0 (3.4)
Where 4Gvdw denote the contribution of Van der Waals contacts between the protein and its lig-
and; 4GH−bond represents the hydrogen bonding between the ligand and the protein; 4Gdeformation
accounts for the deformation effect; 4Ghydrophobic specifies the hydrophobic effect; 4G0 is the re-
gression constant that may contain the translation and rotational entropy loss that occurs on bond-
ing [Wang et al., 1998].
Each term in the function is computed as follows :
Van der Waals (VDW) interaction. The Van der Waals interactions are balance between dispersion
forces and short range repulsion and they play a fundamental role in binding processes, but there is still
disagreement on the best method to calculate them. X-score in its original approaches computed VDW
by simply pairwise counting the VDW bumps between protein and the ligand which simply means that
by summing out Van der Waals radii of the two interacting atoms (i.e atom from protein and Ligand).
In later version of X-Score uses Lennard Jones potential to reflect the balance between the short-range
repulsion and the long-range attractive dispersion force [Wang & Wang, 2001.]. Although there exist
many version of the Lennard Jones potential X-Score uses the so-called 8-4 version which can been



















Where V DW accounts for the Van der Waals interaction energy, calculated by considering all the atom
pairs between the ligand and the protein; dij denotes the distance between the ligand atom i and the
protein atom j; dij,0 = ri + rj the sum of Van der Waals radius of atom i and atom j. In X-score
algorithm only heavy atoms contribute. Hydrogen atoms are neglected [Wang & Wang, 2001.].
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Hydrogen bonding. Hydrogen bonding is the term that gives specificity in the bonding process. This
interaction happens when two atoms get close enough and form a specific donor-acceptor pair. In the
X-Score algorithm, ”a hydrogen bond donor is defined as a nitrogen or oxygen atom with a hydrogen
attached; while an acceptor is defined as a nitrogen, oxygen, or fluorine atom with at least one valence
electron to accept a hydrogen atom. All the atoms in the protein and the ligand are labeled as either
donor (D), acceptor (A), donor/acceptor (DA), or none (N)”, said the authors [Wang et al., 1998].
A hydrogen bond has two parameters: the bond length, i.e the distance between D and A, and the bond
angle, i.e., the angle between D-H...A.
Assuming that hydrogen bond has an ideal geometry and any deviation from it will weaken the strength
of the hydrogen bond. The strength of a hydrogen bond is then computed by considering these three
geometric descriptors [Wang & Wang, 2001.]:
HBij = f(dij)f(θ1,ij)f(θ2,ij) (3.6)
The distance function f(d) and the angular functions f(θ1) and f(θ2) in equation 3.6 are written in the
following simple linear piece-wise forms;
f(d) =

1.0 if d0 ≤ d0 − 0.7Å
1
0.7 × (d0 − d) if d0 − 0.7Å< d < d0
0.0 if d > d0
Where d0 = ri + rj is the Van der Waals distance between the donor and the acceptor and for the
angular functions f(θ1) and f(θ2) we have respectively
f(θ1) =

1.0 if θ1 ≥ 120◦
1
60 × (θ1 − 60) if 60
◦ ≤ θ1 < 120◦
0.0 if θ1 ≤ 60◦
f(θ2) =

1.0 if θ2 ≥ 120◦
1
60 × (θ2 − 60) if 60
◦ ≤ θ2 < 120◦
0.0 if θ2 ≤ 60◦








It is important to emphasise that hydrogen bondings (HB) are stabilising interactions, and it is essentially
a summation of the number of HB, so a large, positive HB is stabilising.
Deformation effect. According to wang :”The deformation effect refers to the conformational changes
that occur during the binding process. On one hand, this causes adverse entropic changes due to freezing
of internal rotations of both the protein and its ligand and on the other hand, it can cause adverse
enthalpic changes due to the strain energy exerted during binding. Based on the principles of statistical
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thermodynamics the entropic changes is usually estimated by using a constant value per rotatable bond
that is frozen, but the enthalpic change is more difficult to elucidate” [Wang et al., 1998].
X-Score algorithm uses the number of rotors in the ligand to estimate the term accounting for entropic
and enthalpic change in the deformation effect. If a rotor is split into halves and assigned onto the two








1.0 if atom i is involved in two rotors
0.5 if atom i is involved in one or more than two rotors;
0.0 if atom i is not involved in any rotor;
We note that according to rotor-counting algorithm, RTi should be 1.5 if atom i is involved in three
rotors and 2.0 if four rotors are involved. This reduction in RTi value reflects the consideration for
offsetting the overstimation of conformational flexibility in the conventional algorithm. Although very
crude, according to the authors, this reduction improves the accuracy X-Score [Wang & Wang, 2001.]
Here RTi is the number of rotors in which ligand atom i is involved. A rotor is defined as acyclic
sp3 − sp3 and sp3 − sp2 single bonds. Rotation of terminal −CH3, −NH2, or −OH, whose rotation
does not produce any new conformation of heavy atoms, are note taken into account. The flexibility of
cyclic portions of the ligand is ignored [Wang et al., 1998].
It’s worth to mention that attempt by the authors to incorporate the deformation effect of the protein
into the computation did not improve the results, probably due to problems associated with estimating
the magnitude and number of charges in amino side chain position on ligand binding.
Hydrophobic effect. Before protein and its ligand form a complex, both protein and ligand are
solvated, and therefore a certain degree of desolvation takes place during binding that undergoes changes
in entropy as well as in enthalpy. One of the consequences is that non-polar groups tend to favor each
other, this is referred as ”Hydrophobic effect”. Accurate characterization is still very difficult to achieve
as it involves complicated interactions such as ligand-water, protein-water, and water-water interactions
before and after binding [Wang & Wang, 2001.].
It is important to note here however that this treatment of desolvation within X-Score is essentially an
enthalpic one only: entropic component of desolvation are much more difficult to compute (not least
because most water molecules are invisible in X-ray structure) and are essentially ignored by X-Score.
Many versions of algorithms have been proposed in other empirical scoring functions to compute hy-
drophobic terms. X-Score has implemented three classes of these algorithms.
1. Hydrophobic surface algorithm. The hydrophobic effect is assumed to be proportional to the
buried hydrophobic surface of the ligand (Equation 3.9). Scoring function such as LUDI uses
this algorithm [Bohm, 1994]. Since there are several types of molecular surfaces, X-Score choose
to use the solvent-accessible surface (SAS). The radius of the solvent probe is set to 1.5 Å. The
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surface areas of hydrogen atoms are attributed to their root atoms. Any part of the ligand surface
is considered buried if it penetrates into the solvent-accessible surface of protein. Let also mention
that only hydrophobic atoms are considered in Equation (3.9). The total amount of buried surface
area is expressed in square Angstrom.
2. Hydrophobic contact. The hydrophobic effect is calculated by summing up the hydrophobic
atom pairs formed between the ligand and the protein. In X-score it is calculated as in Equation
(3.10).
3. Hydrophobic matching algorithm.
In the initial version of X-Score called SCORE [Wang et al., 1998] this algorithm was adopted. Ac-
cording to this method, different parts of the ligand sense the protein differently because of the het-
erogeneous nature of the binding site. If a hydrophobic ligand atom is placed at a hydrophobic site
of the protein, then it is expected to be favorable to the binding process [Wang & Wang, 2001.].















1.0 if d ≤ d0 + 0.5Å
1
1.5 × (d0 − 2.0− d) if d0 + 0.5Å< d ≤ d0 + 2.0Å
0.0 if d > d0 + 2.0Å.




log Pi ×HMi (3.11)
Where HMi is indicator function. It is set to 1 if hydrophobic atom i is placed in a hydrophobic
environment; otherwise it is set to 0. Log Pi refers to the hydrophobic scale of atom i, which is the
contribution of atom i to the n-octanol/water partition coefficient (Log P ) of the molecule. These
scales play the role of weight factors to ensure that more hydrophobic atoms contribute more to the
hydrophobic effect. The ’environment’ of a given ligand atom is defined to consist of all the atoms on
the protein which are within 6 Åfrom ligand atom. The hydrophobic of the environment is determined
by summing up the hydrophobic scales of all its member atoms [Wang & Wang, 2001.].
Overall, X-Score expresses the binding affinity of a given protein-ligand complex in pKd units calculated
by summing up all terms described above. Since three different algorithms for modeling the hydrophobic
effect have been implemented it result that X-Score consist of of three scoring functions:
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pKd,1 = C0,1 + CV DW,1 × V DW + CH−bond,1 ×HB + Crotor,1 ×RT + Chydrophobic,1 ×HP,
pKd,2 = C0,2 + CV DW,2 × V DW + CH−bond,2 ×HB + Crotor,2 ×RT + Chydrophobic,2 ×HM
pKd,3 = C0,3 + CV DW,1 × V DW + CH−bond,3 ×HB + Crotor,3 ×RT + Chydrophobic,3 ×HS
(3.12)
Where C0,i, CV DW,i and the coefficients CH−bond,i, Crotor,1, Chydrophobic,i (i = 1, 2, 3) are adjustable
parameters in the X-Score function: these default value coefficients are determined by regression analysis
of the entire training set.
X-Score is therefore defined as a consensus scoring function which is the arithmetical average of the
three equations of (3.12):
X − Score =




A standard multivariate regression was carried out using the three equations in (3.12) on the training
set to compute the weight or coefficient of each term. Table (3.2) lists all these coefficients.
Term Coefficient


















Table 3.1: Regression models of 3 equations in (3.12)
And the predictive coefficient of determination R2 for the three program implemented in X-Score are
respectively 0.318, 0.319 and 0.249 for the test data. The average value of these three scores gives the
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coefficient of determination of X-Score which is 0.356. In term of goodness of fit we can say that only
35.6% of the test data are explained by the model proposed by X-Score. Investigating the statistical
result for the training data set, R2 for the respective equations in (3.12) is respectively 0.504, 0.546 and
0.571 yielding a R2 of 0.591 for X-Score or in term of goodness of fit only 59.1% of training data set are
explained by X-Score model which is quite a good proportion comparing to test data set where only 35%.
The standard deviation for each algorithm in (3.12) is 1.51 for HPSCORE, 1.61 for HMSCORE
and 1.63 for HSSCORE and taking the average of these values we get the deviation on the test data
set for X-Score [Wang & Wang, 2001.].
A leave-one-out cross validation was performed and gave squared correlation coefficient (Q2) of 0.480,
0.522 and 0.551 and a standard deviation (SPRESS) of 1.62, 1.57 and 1.47.
3.4 Test data set and ranking
The value of any empirical scoring function resides in its capacity to reproduce a binding affinity that
correlates well with experimental data. In the case of X-Score, 11 endothiapepsin complexes in the table
below were used as the test data in the original X-Score work.
Applying X-Score to the test set [Wang et al., 1998] they obtained a computed predictive correlation
of 0.356 and a standard deviation of (spred) of 1.58 pKd units (3.2 kJ/mol at 298 K).
PDB id Resl (Å) Protein/ligand Exp X-Score Rank order Exp Rank order Pred
1eed 2.0 endothiapepsin/PD-125754 4,90 6,15 11 11
1epo 2.0 endothiapepsin/CP-81282 7,96 8,84 3 2
1epp 1.9 endothiapepsin/PD-130693 7,16 6,58 6 10
2er0 3.0 endothiapepsin/L-364099 6,40 7,86 10 4
2er6 2.0 endothiapepsin/H-256 7,22 6,99 5 8
2er7 1.6 endothiapepsin/H-261 9.00 8,67 2 3
2er9 2.2 endothiapepsin/L-363564 7,80 7,83 4 5
3er3 2.0 endothiapepsin/CP-71362 7,10 6,9 7 9
4er1 2.0 endothiapepsin/PD-125967 6,62 7,69 9 6
4er2 2.0 endothiapepsin/pepstatin 9,30 9,27 1 1
4er4 2.1 endothiapepsin/H-142 6,80 7.00 8 7
Table 3.2: Test set and ranking
Figure (3.1 [Wang et al., 1998] shows the correlation between the experimental and computed pKd
value of 11 endothiapepsin complexes in the test set. We notice however that X-Score is not a direct
prediction of the experimental −LogKd as the fitted line has non-zero intercept (2.772) and the gradient
is less than one (i.e 0.664). The test with 30 protein-ligand complexes provided a weak correlation as
the regression yield 0.356 of R2. Meaning that only 35, 6% of the data was explained by the regression
line.
We also noted that from Table (3.2) whilst X-Score correctly predicts the strongest and weakest inter-
actions in this small, focussed data set, it otherwise does not predict the correct rank order, which is
potentially problematic in, for example, drug development applications.
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Figure 3.1: Correlation between the experimental and calculated pKd values of 11 endothiapepsin
complexes in the test set.
3.5 X-Score program
The final scoring function is written in C++ language. X-Score requires a protein file in PDB format
together with the corresponding ligand file in MOL2 format as input to perform the computation. The
program reads in the structure, assigns atom types to it and performs the calculation giving the negative
logarithm of the dissociation constant for a given protein-ligand complex as output. The computation
process for one complex is obtained within a second on SGI O2/R10000 workstation. The computational
results are output into a text file in which the detailed information of each ligand atom, including the
atomic binding score, is tabulated. Atomic binding scores are written into the Mol2 file which stores the
ligand structure so that the user can display the using a visualization software such as SYBYL, VMD,
etc [Wang & Wang, 2001.].
The authors of X-Score suggest that their approach perform well statistically compared to similar method.
Indeed, as shown in Table 3.3, X-Score achieves the best regressional significance (F value) and smallest
standard deviation in cross-validation (sPRESS).
In Table 3.3 [Wang et al., 1998] Samples is the number of complexes used in the training set. Terms
indicate the number of terms in the scoring function, r2 is the squared correlation given by regressional
fitting, and s is the standard deviation in regressional fitting (kJ/mol), F is the Fisher significant ratio, q2
is the squared correlation coefficient given by leave-one-out cross-validation and finally sPRESS standard
deviation in leave-one-out cross-validation (kJ/mol).
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Approach Bohm Head Gschwend Eldridge X-Score
Samples 45 51 103 82 170
Terms 5 13 8 5 6
r2 0.762 0.85 0.745 0.710 0.777
s 7.9 5.8 7.2 8.0 6.6
F 32.1 17.8 39.6 - 57.8
q2 0.696 0.78 0.701 0.658 0.743
sPRESS 9.3 6.5 - 8.7 63
Table 3.3: Comparison of X-SCORE with other similar methods
3.6 Summary
In this chapter we have described X-Score, an empirical scoring function which can be used in structure-
based drug design schemes. The parameters in the function aim to capture the essential energetics of the
protein-ligand binding process. The model as designed is obtained after a regression of 200 complexes
and evaluation against a test set.
Even Table 3.3 presents X-Score as producing a better binding affinity prediction compared to other
scoring function, X-Score has however weaknesses among which we can cite:
1. entropic component of desolvation not considered
2. effectively double counts attractive dispersive force contributions (in both VDW and hydrophobic
terms)
3. simplistic approach to Hydrogen bonding contributions (ignores, for example, the effect of charge
on of strength of H-bonds, irrespective to distance and also appears to ignore sulphur atoms)
4. although overall regression-based coefficients give class-leading r2 values etc. still gets rank order
of ligand binding wrong within a given series (e.g. Table 3.2)
Therefore, there appears to be scope to globally re-parameterise X-Score for better application to
individual protein-families (e.g protein kinases) or individual proteins (e.g Cell Division Kinase CDK2),
as well as to explore the scope to locally reparameterise X-Score based on the dual effect of charged
atomic pairwise interactions between protein and ligand on:
1. H-bond strength and
2. entropy of desolvation on ligand binding.
These therefore form the goals of the remaining chapters of this thesis.
4. Sensitivity and Re-parameterization of
X-Score
In this chapter we assess the robustness of X-Score by measuring its sensitivity when changing suc-
cessively the weight of each term and attempt to re-parameterize the coefficient tailored to a specific
training set data in the group of human Kinase with emphasis on Epidermal growth Factor Receptor, the
CDK2 (cell divsion protein kinase 2), MAPK (Mitogen-activated protein kinase) and the TK (Tyrosine
Kinase).
It is worth mentioning here that we are mainly interested in dissociation constant (Kd) or inhibition
constant (Ki) data and have focussed on these parameters as we aimed to optimise the X-Score coeffi-
cients for our data set of interest in this study. We began by using the data set provided by X-Score to
recompute the X-Score’s pKd and to test for ourselves how well X-Score reproduce experimental pKd.
Since we want to optimize parameters in X-score we are going to make constant use of linear regression
which is the most famous and most widely used in optimization problems. The next two sections will
consist of the statistical method used.
4.1 Statistical analysis
4.1.1 Linear Regression : simple linear regression
This section has been compiled from the book ([Draper & Smith, 1998]) and lecture notes from the
South Africa National Bioinformatic (NBN) Course in 2011 at SANBI [Coetzer, 2011].
The simple linear regression model is a model in which we try to explain a endogenous variable Y as a
function of a single exogenous variable x. It can be expressed as :
Yi = β0 + β1Xi + εi, 1 ≤ i ≤ n (4.1)
where, Y1, Y2, . . . , Yn are n endogenous observations variable (response variable); x1, x2, . . . , xn are n
exogenous (explicative variable); β0 is the parameter associated to x-intercept; β1 is the gradient;εi is
an error term and n is the number of observations.
The variable Y1, Y2, . . . , Yn are observations of one random variable, while x1, x2, . . . , xn they are not
random variable, they are known value (e.g through experiment). β0 and β1 are model parameters,
β0 is the x-intercept and β1 is the slope of the line they are unknown and we must estimate them;
ε1,2 , . . . , εn are error on one random variable.
Interpretation of β0 and β1
β0 is interpreted like the average of value of Y when x is zero and β1 is defined as the average increase
of Y when x changes. If β1 = 0, the distribution of Y in this case does not depend on x. If β0 = 0, the
model has no intercept.
The Figure 2.2 is an illustrative diagram of the simple linear regression model. The line represents the
24
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average value of Y as a function of x. The observations values of Y is randomly distributed around the
straight line representing this average. The error terms are differences between the observed values of Y
and the fitted line. As the variance of these terms is constant in x, the average distance of the points to
the regression line is the same for all values of x. Finally, the absence of pattern between the error terms
means that the value of an error term is not influenced ( linearly) by the value of other error terms.
Sometimes the average value of Y when x is zero is difficult to interpret. We can then choose a centered
version of the model :
Yi = β0 + β1xi + εi (4.2)
= β∗0 + β1(xi − x̄) + εi (4.3)
In the centered version of the model, β0 is interpreted as the average value of Y when x is (̄x).
Model parameters
In simple linear regression one estimate two parameters: β0 and β1. The variance of the residuals in
the assumption of the normality were added to these two parameters. In this section, we show how to
estimate these parameters. We will then focus on the distribution of β0 and β1 parameters and their
interpretation.
In practice, one need to check the assumptions from estimate of the distribution of error terms, rather
than from variables, itself. For this reason, it is possible to reformulate the hypothesis as follows:
H1 : E(εi) = 0 for i ≤ i ≤ n
H2 : V ar(εi) = σ
2 for i ≤ i ≤ n
H3 : Cov(εi, εj) for i ≤ i ≤ n
To these three assumptions, one need sometimes to add the assumption of normality of residuals as
follows:
H4 : ε1, ε2, ..., εn ∼ N(0, σ2)
H4 is generally a stronger assumption used because it allows to build confidence intervals and do
hypothesis testing, depending on the size of data we are dealing with. If the size of data is big, we must
make sure that hypothesis H4 is met otherwise we need to find an alternative test such as non-parametric
test.
Estimation of β0, β1 and σ2
Two approaches are generally accepted to estimate parameter of a statistical model: the least squares
method and the maximum likelihood. This two approaches are equivalent under the assumption of
normality.
textbfLeast Square Method
The aim here is to choose β0 and β1 to minimize the sum of squared residuals i.e :














Yi − β0 − βixi
)2
(4.4)
where εi is an estimate of the error term, also called residual, Yi is the observed value of the response
variable and Ŷi is the predicted value (i.e the position of Yi if it was in the line). Since the function to
be minimized has good properties (including smooth and convex), it can be minimized by taking the
derivatives of the sum relative to β0 and β1, and then equating the derivative to zero and finally solving









We do not get down to necessary mathematical simplification here to compute these estimators as it is
shown in the next paragraph that the least squares method is equivalent to the method of maximum
likelihood under the assumption of normality.
Maximum likelihood method









The implementation of the maximum likelihood method requires the knowledge of the distribution of
observations Y1, Y2, ..., Yn. We have that Yi = (β0 + β1xi) + εi. Since the fourth assumption of
regression (H4: ε1,2 , ..., εn ∼ N(0, σ2)) and knowing that (β0 + β1xi) is a constant, we have that



























































Yi − β0 − β1xi
)2 (4.8)
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before further ado let’s observe that in equation (4.8), we see that the first term contains no β0 nor





is equivalent to minimize
(
Y i − β0 − β1xi
)2
, which corresponds exactly to the
method of least squares.
The criteria (4.4) and (4.8) are equivalent. However, the maximum likelihood method is advantageous
compared to the least squares method: it allows to estimate σ2 directly. This allows us to find the
distribution parameters and predictions and to test hypothesis in our linear model.
Estimate β0





















nȲ − nβ0 − nβ1x̄
) (4.9)
we then set the derivative equal to zero
nȲ − nβ0 − nβ1x̄ = 0
Ȳ − β0 − β1x̄ = 0
Ȳ = β0 + β1x̄
(4.10)
We observe that equation (4.10) means that the regression line necessarily passes through the point
with coordinates (x̄, Ȳ ).
So that from (4.10) we deduce that :
β̂0 = Ȳ − β̂1x̄ (4.11)
Estimate β1





































By setting this derivative equal to zero and substituting β0 for the expression derived from equation












































It is then possible to re-write β1 in the following equivalent form as:
β̂1 =
∑n

































Note that Sxx and Sxy are respectively called the corrected sum of squared of x and the corrected sum
of the cross products of x and Y.
Estimate of σ2
Finally, the last parameter of the model is to estimate is σ2, the variance of the error terms. It is

































Yi − β0 − β1xi
)2
(4.15)
By setting the derivative equal to zero and replacing the parameters β0 and β1 by their estimators, we
have :

















where ε̂i = Yi − Ŷi denote the residues.
4.1.2 Distribution for parameters
It should first be recalled that Yi = β0+β1xi+εi. Since H4 has been assumed that ε1, ..., εn ∼ N (0 , σ2)
and (β0+β1xi) is a constant, it follows that Yi ∼ N (β0+β1xi , σ2). To find the law of the parameters,
we take into account this facts.
Distribution for β̂1







































It should be noted that for the last term of the equation, we used the following two equalities



















We conclude that β̂1 is an unbiased estimator (or good estimator) of β1
































β̂0 can be expressed as a linear combination of Yi as follows:
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it follows that β̂0 is distributed according to a normal distribution. We need now to determine the
parameters of this distribution, i.e the mean and variance values. We can calculate these quantities
using the mean and variance of β̂1. for the mean we have that
















= β0 + β1x̄− β1x̄
= β0
(4.26)
and the variance is calculated as follows







































Confidence intervals and hypothesis tests for β0 and β1
In order to have a confidence interval for β0 and β1 we will use the method where the distribution (
equations (4.28) and ( 4.23)) of these parameters is required. For example, a confidence interval for
β1, one center and reduces the random variable to get




generally not known and must therefore be estimated. The maximum likelihood estimator of this
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quantity is
∑n
i=1 ε̂i which is biased. We therefore use rather unbiased estimator defined by σ
2 = s2 =∑n
i=1 ε̂i/(n−2). In this case, however,
β̂1 − β1√
s2/Sxx






















follows a chi- square distribution with ν = (n − 2) degrees of freedom ( as the sum of the square of








∼ N (0 , 1)√
χ2n−2/(n− 2)
∼ Tn−2
Since this is a ratio of a centered normal random variable and reduced the square root of a chi-squared
variable divided by its degrees of freedom (n - 2), we obtain the distribution of T-Student with (n - 2)
degrees of freedom (Tn−2). From the latter we derived directly the limits of a confidence interval at
level of (1− α)% for β1 with the equation[





where (1− α/2) denotes the (1− α/2)th quantile of a t-distribution with (n - 2 ) degrees of freedom.
Based on the distribution found we can also implement hypothesis tests. The most often tested hypoth-






and P(|tn−2| > |tobs|), where tobs denotes the calculated statistical test, gives us the p- value. If the p-
value is smaller than the selected threshold α , we reject the null hypothesis that β1 = 0. Conversely,
if the p-value is greater than or equal the threshold, we can not reject the null hypothesis that β1 = 0
. in this case, we deduce that x has no explanatory power on Y. It is possible to build in the same way
a confidence interval and hypothesis testing for β0.
In the same fashion it is possible to build in a confidence interval and hypothesis testing for β0. The
confidence interval for the intercept can be expressed as :
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In the case where the null hypothesis that the intercept β0 = 0 can not be rejected, the model can be
simplified as follows
Yi = β1xi + εi
4.1.3 Distribution of residues
In the model Yi = β̂0 + β̂1xi, Yi denotes the ith predicted value, also called prediction, and Yi− Ŷi = ε̂i
is called the ith residue.
The residuals of the model (, ...,) constitute part of the model (part of Y) unexplained by x. Residues
can be seen as pseudo observations that tell us about the error terms.
Following the same approach as for the parameters, we calculate the distribution of residues by expressing
them as a linear combination of Yi as follows:
ε̂j = Yj − ĵ























− 1n + aj(x̄− xj) if i = j
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Residues therefore follow a normal distribution






It should be noted that the sum of the residuals is always exactly equal to zero, which means that they
are dependent variables.
4.1.4 Distribution of a prediction
It is common, although this is not always the case, the goal of regression is to predict a new value. We
then distinguishes two cases:
1. Estimate Y0, the mean value of Y predicted by the model for an exogenous variable value x = x0.
2. Estimate the value any observation of Y when the exogenous variable x takes the value 0. This
value will be denoted by Ŷ0
∗
.
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Prediction of the average value Y0 for x = x0
Let Ŷ0 be a predictive value, the average value of Y predicted by the model when x = x0. We have
that Ŷ0 = β̂0 + β̂1x0. Again, we use the fact that Yi ∼ N (β0 + β1xi , σ2) to find the distribution of
Ŷ0. Was first expressed Ŷ0 as a linear combination of Yi as follows:



































n − aix̄+ aix0
)
We can show that
∑n
i=1 ci = 1, that
∑n







































From this result, it is possible to calculate a confidence interval around the predicted mean value by
replacing σ2 by its estimator s2. Using the same fashion as above, we obtain the confidence interval of
level (1 - ) to Ŷ0 as follow:
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Prediction of Y for x = x0
It is important to understand that the confidence interval defined in equation (4.36 relates to the mean
of Ŷ0. To build what is called a prediction interval, we must consider both the variance related to the
model (the estimation of parameters) and the variance of the error term (ε). However, equation (4.35)
does not take into account the variance of the error term. The variance of this term is σ2. If we denote
the average prediction for x = x0 by Ŷ0 = β̂0 + β̂1x0 and the prediction by Ŷ0
∗
= β̂0 + β̂1x0 + ε, we
will have

































It is therefore possible to calculate the confidence interval at level (1 - ) for Ŷ0
∗
and we is obtained
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The mean value of Ŷ0
∗
and of 0̂ are equal because the mean value of the error terms is zero. It is
important to note that the prediction interval is always wider than the confidence interval for Ŷ0.
By analyzing the formulas (4.35) and (4.37), we find that the variances decrease when n increases or
Sxx increases. This means that the higher the sample size is large and/or more there is variability in
the values of the exogenous variable, the estimates will be more accurate. In contrary, more the point
x0 for which a prediction is required is far from the center (x̄) of the explanatory variables more the
prediction will be inaccurate. It is important to take these comments into consideration when planning
experiments.
4.1.5 Analysis of Variance : ANOVA
The analysis of variance is one of the vast topic to linear modelling. Here, We will just give a little
introduction needed to understand the regression. We will see in this subsection how the variability in
the observations of the endogenous variable Y1, . . . , Yn can be decomposed as the linear regression
model. This decomposition is the basis of the adjustment model tests. We have that
n∑
i=1
(Yi − Ŷ )2 =
n∑
i=1




(Yi − Ŷi)2 +
n∑
i=1
(Yi − Ȳ )2 + 2
n∑
i=1




(Yi − Ŷi)2 +
n∑
i=1
(Ŷ − Ȳ )2
If the sum of the total square SStot =
∑n
i=1(Yi − Ȳ )2, the sum of squares due to regression SSreg =∑n
i=1(Yi − Ȳ )2 and the sum of residual squares SSres =
∑n
i=1(Yi − Ŷi)2, then we have that
SStot = SSreg + SSres (4.39)
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We understand why this nomenclature for the various sums of squares by examining Table 2.3 that
summarizes the analysis of variance. Equation (4.39) is predominant in regression. The total sum of
squares SStot quantify the variability in Yi. Equation (4.39) means that this variability is divided into
two parts: the sum of squares due to regression (SSreg) and the sum of square of the residual(SSres).
The sum of squares due to regression SSreg quantifies the variability in the estimates or prevision Ŷi,
i = 1, ..., n. Since Ŷi, vary only with respect to xi, i = 1, ..., n, we have that this sum of square is the
part of the variability in the Yi explained by the fact that all observations do not have the same value
for xi.
The residual sum of squares SSres measure the variability in the (Y i − Ŷi). This variability is caused
by the fact that the value of Yi is not fully explained by the regression model.
The Table (4.1) presents the main elements of the analysis of variance.
Table 4.1: Table of analysis of variance in the case of simple linear regression having the source, the
number of degrees of freedom, sum of squares, mean square and the Fisher statistic F
Source Degree of freedom Sum of squares (SS) Mean Square (MS) F
Model 1 SSreg =
∑n
i=1(Ŷi − x̄)2 MSreg =
SSreg
1 MSreg/MSres
Residual error n -2 SSres =
∑n
i=1(Yi − Ŷi)2 MSres =
SSres
n−2
Total n-1 = n-2 + 1 SStot =
∑n
i=1(Yi − Ȳ )2
In Table (4.1) of Analysis of variance, each sum of the squares has a number of degrees of freedom of
its own (shown in the second column of the table), namely:
• SSreg has a single degree of freedom (df = 1) as in the simple linear regression model there is
only one explanatory (exogenous) variable.
• In SSres is associated to (n - 2) degrees of freedom since we estimated two parameters in the
regression model (β0 and β1), so we have n observations minus 2 parameters.
• SStot has (n - 1) degrees of freedom because there are n observations minus one average. It is
worth to note that the number of degrees of freedom of SStot is equal to the sum of the number
of degrees of freedom of SSreg and SSres
The sum of squares due to regression (SSreg) is the portion of variance explained by the model. The
residual sum of squares (SSres) is the part that the model does not explain. Intuitively, if the proportion
of the variance explained by the model (SSreg/SStot) is high, the model is good.
It is worth to emphasize that the residual mean square error (SMres) is the estimate of the variance of















The analysis of variance allows an overall test of the regression. We wish to test the null hypothesis
H0: Yi = β0 + εi against the alternative hypothesis H1: Yi = β0 + β1xi + εi. The idea is to compare
SSreg to SSres to assess whether exogenous variable explains a significant part of SStot. We have
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already mentioned that if the proportion of variance explained by the model (SSreg/SStot) is high, the
model is good. To make the overall test, we instead use the ratio of mean squares (MSreg/MSres).



















∼ (Tn−2)2 ∼ F1,n−2
In the last equality we used the fact that if the random variable T is distributed according to the
T Student with k degrees of freedom (denoted Tk), then the random variable T 2 follows the law of
Fisher-Snedecor with 1 and k degrees of freedom (denoted F1,k).
So we will reject H0 at α level if F > F1,n−2(1−α). The p-value of the Fisher-Snedecor test indicates
whether the exogenous variable has a significant effect on the value of the endogenous variable. A low
p-value (e.g, if the p-value < 0.05) means that the effect of the exogenous variable is significant. As
part of the simple linear regression, the Fisher-Snedecor test is exactly equal to the nullity of the slope
H0: β1 = 0. This case does not however generalize for the Multiple linear regression.
4.1.6 Quality of the model
To assess the quality of the model, we look at the following criteria:
• The Fisher test and the test of nullity of β1. Both tests are equivalent under the simple linear
regression. If the conclusion of the test is that β1 = 0, the model is inadequate, that is to say
that the explanatory variable (exogenous) does not have significant effect on the response variable
(endogenous).
• Coefficient of determination (R2).
R2 = Corr(Y , Ŷ ) =
( ∑n
i=1(Yi − Ȳ )(Ŷ − Ȳ )√∑n
i=1(Yi − Ȳ )2
∑n





When R2 = 0, all the variability is due to random error and the model explains absolutely nothing about
the value of Yi. When R
2 = 1, all points are aligned on the regression line, that is to say that the
model fit is perfect and the value of Yi is an exact function of xi. R
2 is interpreted as the percentage
of variance explained by the model. A high value indicates that the model is good. The threshold for
considering that R2 is high, varies and quite subjective. In particular, it depends on the objectives of
the regression and the domain of application.
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4.1.7 Assumption in the model
After adjusting the model, it is important to check certain assumptions such as:
H1: E[εi] = 0 (linearity)
H2: Var[εi] = σ2
H3: Cov(εi, εj) = 0 (No correlation)
H4: ε1, ..., εn follow normal distribution(normality)
If these are not met, the linear regression is not an appropriate model and it will be necessary for example
to transform variables or to use another type of model.
4.1.8 Multiple linear regression
Matrix notation for simple linear regression
The study of linear regression can be greatly deepened using matrix notation and results of linear algebra.
Before addressing the multiple linear regression, we consider the matrix notation in the case of simple
linear regression.
Let Y, the vector of dimension (n × 1) for endogenous variables, X a (n × 2) matrix of exogenous




















































Using these notations, the simple linear regression model defined in equation (4.57) can be written as:
Y = Xβ + ε (4.40)
Introduction
Many regression problems involve several exogenous variables. Such approaches are called multiple
regression models. Multiple linear regression remains one of the most applied statistical methods. Here
we have more than one predictor.
The multiple linear regression make a relationship betwee one endogenous variable Y with multiple
exogenous variables (x1, x2, . . . , xp).
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Model and Notation
The multiple linear regression model is a generalization of the simple linear regression model when
considering several explanatory variables (exogenous). The equation of the multiple linear regression
model can be written by the mathematical formula as follows:
Yi = β0 + β1xi1 + β2xi2 + . . .+ βpxip + εi (4.41)
where,
• Yi, i = 1, . . . , n, represent the endogenous random variable.
• xij , i = 1, . . . , n; j = 1, . . . , p, denote the exogenous variables. These are known numbers, not
random. It is possible to multiply β0 by the variable xi0 = 1 , i = 1, . . . , n. In this case, β0
represents a constant called Intercept.
• β0 and βj , j = 1, . . . , p denote the model parameters are unknown and therefore must be
estimated.
• εi, i = 1, . . . , n are the unknow random variables error terms .
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or simply short hand notation
Yn×1 = Xn×p′βp′×1 + εn×1 (4.42)
where,
• Y designates the vector containing the endogenous variable size (n× 1)
• X notes the incidence matrix containing the exogenous variables (size n× p′)
• β is the vector of regression coefficients ( size p′ × 1 )
• denotes of the error vector terms ( size n× 1)
• n denotes the number of observations
• p is the number of exogenous variables
• p′ = p+ 1 is the number of the exogenous variables plus intercept
Section 4.1. Statistical analysis Page 41
Estimating regression parameters
As in the case of simple linear regression, we adopt again the Legendre’s principle of least squares. One




The residual vector can be expressed as
ε̂ = (ε̂1, ε̂2, . . . , ε̂n)




2 = ε̂′ε̂ = (Y −Xβ̂)′(Y −Xβ̂) = f(β̂)
using matrices property we have that
f(β̂) = (Y ′ − (X ′β̂)′)(Y −Xβ̂)
= Y Y ′ − Y ′Xβ̂ − (Xβ̂)′ + (Xβ̂)′(Xβ̂)
= Y ′Y − 2β̂′X ′Y − β̂′X ′Xβ̂
In the last equality we used the fact that Y ′Xβ̂ = (XŶ )′Y = β̂′X ′Y .
We have then a quadratic function of β̂. To minimize
∑n
i=1 ε̂i
2, we differentiate f(β̂) with respect to























= −2X ′Y + 22X ′Xβ̂ = 0
We need to have X ′Xβ = X ′Y . In the case where the matrix X ′X is invertible matrix we have that,
β̂ = (X ′X)−1X ′Y (4.43)
If X ′X is not invertible matrix, one row of this matrix is a linear combination of others and it is necessary
to get rid of this variable. In this case (4.43) has not unique solution.
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4.1.9 Analysis of variance
In general, the n observed values Y1, . . . , Yn, the endogenous variable are not all equal, that is to say
that we observe the variability in the value of the endogenous variable. One goal of regression is to
explain the largest possible part of the variability of the values from exogenous variables.
Thus, considering the decomposition of variability in the value of the following endogenous variable,
 variability of
Y1, . . . , Yn
 =
 variability explained by





we want a model in which a large portion of the variability is explained by the variability in the exogenous


























































































Y ′Y − nȲ 2 =
(
β̂′X ′Xβ̂ − nȲ 2
)
+ ε̂′ε̂
SStot = SSreg + SSres
(4.45)
For each square sum, a number of degrees of freedom is assigned. The degrees of freedom are in fact
the number of independent terms we need to know the value in order to calculate the sum of squares.
For example SStot has n − 1 degrees of freedom, since only n − 1 terms of (Y1 − Ȳ ), . . . , (Y n − Ȳ )
are independent (we know that their sum is 0, so if we known the value of (n − 1) of them, we can
calculate the value of the nth).
Sums of squares and degrees of freedom are generally summarized in an analysis of variance Table
(ANOVA). Table 4.2 summarizes the ANOVA standard Table, while Table 4.3 shows the ANOVA Table
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decomposes the variability from 0 in three parts: one part due to intercept a second part due to external
(exogenous) variable the third part due to random fluctuation. The F Column of the ANOVA Tables
will be explained in the next section. In practice, we work almost exclusively with the ANOVA standard
table .
Chart analysis of variance in the case of multiple linear regression with source, the number of degrees
of freedom, sum of squares, mean square and Fisher statistic F
Table 4.2: Table of analysis of variance in the case of multiple linear regression with the source, the
number of degrees of freedom, sum of squares, mean square and the Fisher statistic F
Source Degree of freedom Sum of squares (SS) Mean Square (MS) F
























Table 4.3: Table of analysis of variance including the effect of β0. Difference between total sum of
squares and the total sum of squares corrected is that the first measures the variability of Yi with respect
to 0, while the second measures the variability of Yi relative to their average.





























4.1.10 F-test of the overall significance of the regression
An important hypothesis testing in regression is to test if at least one exogenous variables explains a
significant part of the variability in Yi. This mean to test whether the data show some evidence against
the null hypothesis H0: the exogenous variables explain nothing. Mathematically, an exogenous variable
does not explain the value of Yi if the corresponding regression coefficient is equal to 0. So we want to
test
H0 : β1 = β2 = . . . = βp = 0
H1 : at least one of the coefficients is not zero
Under H0, the regression model should not explain the variability in Yi and therefore the ratio
SSreg
SSres
should take a small value. By contrast under H1, the regression model should explain some of the
variability of Yi and therefore
SSreg
SSres
ratio should take a great value. To determine whether the value
of the ratio is ”small” or ”large”, we standardizes the ratio for the F statistic from the ANOVA table










Under H0, the statistic F follows a Fisher-Snedecor with p degrees of freedom in the numerator and
(n − p′) degrees of freedom in the denominator. We therefore reject H0 at α level (that is, the data
show that the model is not completely useless, or that there is relationship between the endogenous
variable and at least one exogenous variables) when the F statistic is greater than or equal to the
quantile Fp,n−p′ (1− α)
4.2 Recomputing X-Score
4.2.1 X-Score: Consensus scoring functions
The binary code, we received from the X-Score authors show that X-Score is a combination of three
scoring functions as three algorithms are implemented from modeling the hydrophobic effect. The
hydrophobic effect is calculated either by buried solvent-accessible molecular surface, or by the number
of hydrophobic contacts between protein and the ligand or by the hydrophobic matching of the ligand
with binding site. Recall that, the three functions in X-score are conceptually written as in equations
(3.1), (3.2) and (3.3) in chapter 3.
The final X-score score is found by computing the mean of the three scores namely HPSCORE,
HMSCORE and HSSCORE scores. i.e




In this section we use the data set provided by X-Score (Table 4.4) to re-compute the X-score pKd and
find out for ourselves how well X-score performs.
4.2.3 Data set : X-Score provided data (”ad hoc”)
The Table 4.4 gives both the predicted (Pred) X-Score pKd and the observed or experimental values
(Exp) of −log Kd or −log Ki. The PDB ID for the protein-ligand complex used and the number of
rotors in the ligand are also shown. The data set in Table 4.4 will be referring as ”Ad hoc” data. These
data was provided by the author of the program to test how well X-Score perform and from the data
we computed the predicted score using X-Score.
Table 4.4: ”ad hoc” data for all complex list used for X-score
computation.
PDB ID Exp Pred resolution in Å rotor description
1a46 5.70 7.66 2.12 13 thrombin/beta-strand mimetic inhibitor
1a5g 10.15 7.38 2.06 14 thrombin/peptide inhibitor
Continued. . .
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PDB Exp Pred resolution rotor description
1abe 6.52 5.22 1.70 0 L-arabinose binding protein/L-arabinose
1abf 5.42 5.57 1.90 4 L-arabinose binding protein/D-fucose
1adb 7.69 7.67 2.40 11 alcohol dehydrogenase/CNAD
1add 5.74 5.82 2.40 2 adenosine deaminase/1-deaza-adenosine
1af2 3.10 5.40 2.30 2 cytidine deaminase/uridine
1apb 5.82 5.51 1.76 5 L-arabinose binding protein/D-fucose
1apt 9.40 6.94 1.80 20 penicillopepsin/pepstatin analogue
1apw 8.00 7.17 1.80 15 penicillopepsin/IvaValValDfo-N-methylamide
1b5g 8.00 7.45 2.07 11 serine protease/peptide mimetic inhibitor
1ba8 9.00 6.64 1.80 11 serine protease/peptide mimetic inhibitor
1bap 6.85 5.18 1.75 4 L-arabinose binding protein/L-arabinose
1bb0 8.36 6.75 2.10 11 serine protease/peptide mimetic inhibitor
1bbz 5.82 6.80 1.65 17 ABL tyrosine kinase/peptide ligand
1bcu 5.00 5.70 2.00 2 thrombin/proflavin
1bhf 4.38 5.85 1.80 20 tyrosine kinase P56LCK/ACE-IPA-GLU-GLU-ILE
1bra 1.82 5.10 2.20 1 trypsin mutant/benzamidine
1bxo 10.00 8.48 0.95 10 penicillopepsin/phosphonate inhibitor
1bzm 6.03 5.25 2.00 3 carbonic anhydrase I/sulfonamide drug
1cbx 6.35 5.90 2.00 5 carboxypeptidase A/L-benzylsuccinate
1cla 5.28 5.57 2.34 8 chloramphenicol acetyltransferase/chloramphenicol
1d3d 9.09 7.63 2.04 10 thrombin/benzo[B]thiophene inhibitor
1d3p 7.39 7.26 2.10 12 thrombin/benzo[B]thiophene inhibitor
1dhf 7.40 6.6 2.30 10 dihydrofolate reductase/folate
1dr1 5.57 5.48 2.20 5 dihydrofolate reductase/biopterin
1drf 7.44 6.89 2.00 10 dihydrofolate reductase/folate
1e96 5.22 6.92 2.40 8 RAC/P67phox
1ela 6.35 6.65 1.80 11 elastase/TFA-LYS-PRO-ISO
1etr 7.41 6.77 2.20 10 thrombin/MQPA
1ets 8.22 7.75 2.30 9 thrombin/NAPAP
1exw 3.90 6.04 2.40 15 palmitoyl protein thioesterase/hexadecylsulfonyl fluoride
1fkb 9.70 8.64 1.70 9 FK506 binding protein/rapamycin
1fkf 9.40 7.94 1.70 9 FK506 binding protein/FK506
1fmo 8.64 5.78 2.20 6 phosphotransferase/inhibitor PKI(5-24)
1hsl 7.30 5.08 1.89 4 histidine binding protein/histidine
1hvr 9.51 10.16 1.80 10 HIV-1 protease/XK263
1inc 8.00 6.35 1.94 8 porcine pancreatic elastase/benzoxazinone inhibitor
1mnc 9.00 6.56 2.10 9 neutrophil collagenase/hydroxamate
1ppc 6.16 6.91 1.80 10 trypsin/NAPAP
1pph 6.22 6.52 1.90 5 trypsin/3-TAPAP
1rbp 6.72 7.54 2.00 6 retinol binding protein/retinol
1rgk 4.31 5.14 1.87 7 ribonuclease T1/2’-AMP
1rgl 4.43 5.04 2.00 8 ribonuclease T1/2’-GMP
1rnt 5.18 5.45 1.90 7 ribonuclease T1/2’-GMP
1sre 4.00 6.76 1.78 4 streptavidin/HABA
1tet 6.20 4.34 2.30 6 IGG1 monoclonal fab fragment/CTP3
1tha 5.35 5.50 2.00 7 transthyretin/3 3’-diiodo-L-thyronine
Continued. . .
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PDB Exp Pred resolution rotor description
1tlp 7.56 7.45 2.30 11 thermolysin/phosphoramidon
1tmn 7.47 7.07 1.90 13 thermolysin/N-(1-carboxy-3-phenyl)-L-Leu-Trp
1tng 2.93 4.88 1.80 2 trypsin/aminomethylcyclohexane
1tnh 3.37 4.87 1.80 2 trypsin/4-fluorobenzylamine
1tni 1.70 4.95 1.90 5 trypsin/4-phenylbutylamine
1tnj 1.96 4.98 1.80 3 trypsin/2-phenylethylamine
1tnk 1.49 5.00 1.80 4 trypsin/3-phenylpropylamine
1tnl 1.88 5.17 1.90 2 trypsin/t-2-phenylcyclopropylamine
1yyy 5.09 5.77 2.10 9 serine protease/CVS1695
1zzz 5.13 5.59 1.90 9 serine protease/CVS1694
2ak3 3.86 5.73 1.90 7 adenylate kinase isoenzyme-3/AMP
2cgr 7.27 7.05 2.20 7 KAPPA fab fragment/antigen GAS
2csc 3.36 4.51 1.70 4 citrate synthase/D-malate
2ctc 3.89 5.53 1.40 4 carboxypeptidase A/L-phenyl lactate
2gbp 7.40 5.56 1.90 6 galactose binding protein/galactose
2pk4 4.32 4.37 2.25 6 plasminogen kringle 4/aminocaproic acid
2qwb 2.74 5.41 2.00 10 neuraminidase/sialic acid
2qwc 3.55 5.41 1.60 4 neuraminidase/neu5ac2en
2qwd 4.85 5.35 2.00 10 neuraminidase/4-amino-neu5ac2en
2qwe 7.48 5.70 2.00 10 neuraminidase/4-guanidino-neu5ac2en
2qwf 5.67 5.75 1.90 6 neuraminidase/ligand G20
2qwg 8.40 5.54 1.80 6 neuraminidase/ligand G28
2sns 6.70 5.69 1.50 4 staphylococcal nuclease/2’-deoxy-3’ 5’-diphosphothymidine
2tmn 5.89 5.25 1.60 6 thermolysin/N-phosphory-L-leucinamide
2xim 2.28 4.55 2.30 4 D-xylose isomerase/xylitol
2xis 5.82 4.59 1.71 5 xylose isomerase/xylitol
3cla 4.94 4.31 1.75 8 chloramphenicol acetyltransferase/chloramphenicol
3cpa 4.00 5.60 2.00 5 carboxypeptidase A/glycyl-L-tyrosine
3fx2 9.30 7.49 1.90 10 flavodoxin/riboflavin monophosphate
3ptb 4.50 5.18 1.70 0 trypsin/benzamidine
3tmn 5.90 6.12 1.70 8 thermolysin/Val-Trp
4cla 5.47 5.52 2.00 8 chloramphenicol acetyltransferase/chloramphenicol
4sga 3.27 6.65 1.80 8 proteinase A/Ace-Pro-Ala-Pro-Phe
4tim 2.16 4.89 2.40 5 triosephosphate isomerase/2-phosphoglycerate
4tln 3.72 4.86 2.30 4 thermolysin/Leu-NHOH
4xia 1.54 4.81 2.30 5 D-xylose isomerase/D-sorbitol
5abp 6.64 5.49 1.80 6 L-arabinose binding protein/D-galactose
5cna 2.00 4.85 2.00 6 concanavalin A/a-Me-D-mannopyranoside
5p21 5.32 6.55 1.35 8 ras p21 protein/GPPNP
5sga 2.85 6.71 1.80 9 proteinase A/Ace-Pro-Ala-Pro-Tyr
5tln 6.37 5.93 2.30 8 thermolysin/benzylmalonyl-l-alanylglycine-p-nitroanilide
6abp 5.64 5.19 1.67 0 L-arabinose binding protein/L-arabinose
6rnt 2.37 5.25 1.80 7 ribonuclease T1/2’-AMP
6tim 3.21 4.81 2.20 6 triosephosphate isomerase/glycerol-3-phosphate
7abp 5.54 5.55 1.67 0 L-arabinose binding protein/D-fucose
7est 7.60 6.35 1.80 8 elastase/TFAP
Continued. . .
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PDB Exp Pred resolution rotor description
7tim 5.40 4.84 1.90 4 triosephosphate isomerase/phosphoglycolohydroxamate
7tln 2.47 5.24 2.30 7 thermolysin/CH2CO-Leu-OCH3
8abp 4.00 5.48 1.49 1 L-arabinose binding protein/D-galactose
8xia 2.95 4.46 1.90 4 D-xylose isomerase/D-xylose
9aat 8.22 5.55 2.20 6 aspartate aminotransferase/pyridoxal-5’-phosphate
9abp 8.00 5.43 1.97 6 L-arabinose binding protein/D-galactose
Here, Exp and Pred stand for experimental and predicted pKd values respectively and we computed the
pKd values for these protein-ligand complexes using X-Score utility and open babel to prepare separately
inputs files i.e protein and ligand files.
Model et postulats
The observed dependence of the X-Score pKd value on the experimental value can be shown by a
straight line. The regression line of variable X-score pKd (or calculated score) ( Y ), on observed score
(X) has the form i.e β0 + β1X. Then the linear model can be written as :
X-score(Y ) = β0 + β1 experimental score(X)
The model assumptions include:
1. The linearity of the relationship
2. Homoscedasticity
3. Independence and
4. The normality of residuals
Since the objective is a predict the dissociation constant (pKd), the assumption of normality must be
satisfied.
Parameters estimation
The objective of the previous section was to show how linear regression work and how to apply it. There
are a number of software packages available for performing least square regression. The regression
parameters were estimated using R software [R Development Core Team, 2011.]. The results are
summarized in Table 4.5. The Fisher test table analysis of variance shows that the model is useful
(p− value < 2.2e− 16). The coefficient of determination R2 is 0.6130677. The interpretation of this
value is the following: about 61% of the variance of the computed dissociation constant is described by
the experimental data. As expected, the adjusted R2 is slightly less than R2, but given the sample size,
the difference is not very large. The coefficient of variation is 19
The coefficients β0 and β1 are both significantly different from zero; p-values are, respectively, 4.03e−16
and 2e− 16, which is well below the 5% threshold generally fixed. Confidence interval at 95% for β̂0 is
constructed as follows:
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The interval at 95% for β̂1 is
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Table 4.5: Analysis of Variance table
Sourcee df SS MS = SS/df F Pr > F
Regression 1 144.71 144.712 155.29937 < 2.2e− 16
Residual 97 91.31906 s2 = 0.9318271
Total 98 236.0313
Root Mean Square Error (RMSE) 0.970275 R-squared 0.6131 Adjusted R-squared 0.6091
Coeffients dof Estimate value Std.Error t-value Pr >| t |
Intercept 1 2.67207 0.27325 9.775 4.03e− 16
Gradient 1 0.54446 0.04392 12.397 < 2e− 16
The fitted equation is thus
Ŷ = b0 + b1X
= 2.6721 + 0.5445X.
The foregoing form of Ŷ shows that b0 = 2.6721. The fitted regression line is plotted in Figure (4.1).
We can tabulate for each of 100 values of Xi for which Yi observation is available, the fitted value Ŷi,
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and the residual Yi − Ŷi as in Table (4.6). The residuals are given to the same number of places as
the original data. They are the ”estimates of the errors, εi” and can be written as ei = Yi − Ŷi in a
corresponding notation.
We relied on ”R” software to compute b0 and b1 the estimates value of β0 and β1 but we can check by
a straight forward calculation that
b0 = Ȳ − b1X̄ (4.47)
where Ȳ and X̄ are the mean of the observation of Yi and Xi. Substituting equation (4.47) into
equation (4.1) gives the estimated regression equation in the alternative form:
Ŷ = Ȳ + b1(X − X̄) (4.48)
From equation (4.48), we see clearly that if we set X = X̄, then Ŷ = Ȳ . This means that the center
of gravity of the data set (X̄ , Ȳ ) lies on the fitted line.
We now substitute equation (4.48) into the expression of ”estimates errors” ei written above









We can sum both side to obtain,
n∑
i=1
(Yi − Ŷi) =
n∑
i=1
(Yi − Ȳ )− b1
n∑
i=1
(Xi − X̄) = 0
The above calculation suggests that the residuals sum to zero, in theory. In our case due to the rounding
the residual sum is not exactly zero, but rather −0.028645 as it is in practice.
Table 4.6: Observations, Fitted values, and Residuals
PDBID Yi Ŷi Yi − Ŷi
1a5g 7.66 8.20 -0.54
1a46 7.3 5.78 1.52
1abf 5.54 5.62 -0.08
1add 5.74 6.34 -0.60
1af2 5.35 4.36 0.99
1apb 5.52 5.84 -0.32
1apw 6.87 7.03 -0.16
1b5g 7.05 7.03 0.02
1ba8 6.07 7.57 -1.50
1bap 5.15 6.40 -1.25
1bb0 6.75 7.22 -0.47
1bbz 6.68 5.84 0.84
1bcu 6.25 4.46 1.79
Continued. . .
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PDB ID Yi Ŷi Yi − Ŷi
1bhf 5.83 5.06 0.77
1bra 5.02 3.66 1.36
1bxo 8.4 8.12 0.28
1cbx 5.86 6.13 -0.27
1d3d 7.42 7.62 -0.20
1d3p 6.73 6.70 0.03
1e96 6.57 5.70 0.87
1ela 6.29 6.14 0.15
1ets 7.47 7.15 0.32
1exw 5.94 4.80 1.14
1fkb 8.37 7.95 0.42
1fkf 7.78 7.79 -0.01
1fmo 5.72 7.38 -1.66
1hsl 4.97 6.59 -1.62
1hvr 9.96 7.85 2.11
1inc 6.26 7.76 -1.50
1ppc 6.81 6.03 0.78
1pph 6.48 5.90 0.58
1rbp 7.25 6.33 0.92
1rgk 5.18 5.02 0.16
1rgl 5.02 5.08 -0.06
1rnt 5.29 5.50 -0.21
1sre 6.45 4.77 1.68
1tet 4.42 5.98 -1.56
1tlp 7.38 6.78 0.60
1tmn 6.77 6.65 0.12
1tng 4.8 4.27 0.53
1tnh 4.79 4.51 0.28
1tni 4.74 4.85 -0.11
1tnj 4.88 3.74 1.14
1tnk 4.96 3.48 1.48
1tnl 5.05 3.70 1.35
1yyy 5.56 5.44 0.12
1zzz 5.53 5.47 0.06
2cgr 6.97 6.64 0.33
2ctc 5.2 4.79 0.41
2qwb 5.18 4.16 1.02
2qwc 5.22 4.61 0.61
2qwd 5.36 5.31 0.05
2qwe 5.45 6.74 -1.29
2qwf 5.46 5.76 -0.30
2tmn 5.24 5.88 -0.64
4sga 6.61 6.65 -0.04
4tim 4.88 3.85 1.03
5abp 5.45 6.29 -0.84
5tln 5.55 6.14 -0.59
Continued. . .
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PDB ID Yi Ŷi Yi − Ŷi
6abp 5.18 6.14 -0.96
6rnt 5.28 3.96 1.32
6tim 4.83 6.05 -1.22
7abp 5.51 6.19 -0.68
8abp 5.42 7.03 -1.61
9abp 5.43 7.03 -1.60
1bzm 6.03 5.96 0.07
1cla 5.28 5.55 -0.27
1dhf 7.4 6.70 0.70
1dr1 5.57 5.70 -0.13
1drf 7.44 6.72 0.72
1etr 7.41 6.71 0.70
1mnc 9 7.57 1.43
1tha 5.35 5.59 -0.24
2ak3 3.86 4.77 -0.91
2csc 3.36 4.50 -1.14
2gbp 7.4 6.70 0.70
2pk4 4.32 5.02 -0.70
2qwg 8.4 7.25 1.15
2sns 6.7 6.32 0.38
2xim 2.28 3.91 -1.63
2xis 5.82 5.84 -0.02
3cla 4.94 5.36 -0.42
3cpa 4 4.85 -0.85
3fx2 9.3 7.74 1.56
3ptb 4.5 5.12 -0.62
3tmn 5.9 5.88 0.02
4cla 5.47 5.65 -0.18
4tln 3.72 4.70 -0.98
4xia 1.54 3.51 -1.97
5cna 2 3.76 -1.76
5p21 5.32 5.57 -0.25
5sga 2.85 4.22 -1.37
7est 7.6 6.81 0.79
7tim 5.4 5.61 -0.21
7tln 2.47 4.02 -1.55
8xia 2.95 4.28 -1.33
9aat 8.22 7.15 1.07
1abe 6.52 6.22 0.30
1apt 9.4 7.79 1.61
4.3 Sensitivity of X-Score
We tested the sensitivity of X-Score on the target training data set of interest shown in Table 4.7
which is made of protein ligand complexes from the kinase protein family. Here I computed HPScore,
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Figure 4.1: Plot of the data set and the least square line.
HMScore and HSScore values with X-Score utility and I prepared the protein and input file with open
babel. Average gives pKd values for X-Score as the finale score using the equation (4.46) which is a
consensus between the three scoring functions.
Table 4.7: Kinase training data set
PDB /Ligand ID HPScore HMScore HSScore Average Observed
1b38/ATP 6.02 6.19 5.81 6.01 6.60
1b39/ATP 5.93 6.07 5.70 5.90 6.92
1e1v/CMG 5.65 5.58 5.76 5.66 4.92
1e1x/NW1 5.46 5.39 5.51 5.46 5.89
1h1p/CMG 5.53 5.49 5.64 5.56 4.92
1h1s/4SP 6.56 6.77 6.59 6.64 8.22
1jsv/U55 5.48 5.68 5.23 5.46 5.70
1kv1/BMU 6.90 7.42 6.89 7.07 5.94
1kv2/B96 9.05 9.17 8.66 8.96 10.00
1pf8/SU9 6.12 6.11 5.51 5.91 7.51
1pxm/CK5 6.23 6.30 6.28 6.27 7.22
1pxn/CK6 6.30 6.32 6.18 6.27 7.15
1pxo/CK7 7.12 6.59 6.67 6.79 8.70
1pxp/CK8 6.33 6.51 6.37 6.41 6.66
1q4l/679 6.54 7.15 6.54 6.74 7.40
1y8o/ADP 5.21 5.30 4.99 5.17 5.89
2c6o/4SP 6.61 6.53 6.68 6.61 8.22
Continued. . .
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PDB /Ligand ID HPScore HMScore HSScore Average Observe
2clx/F18 5.54 5.76 5.28 5.53 4.88
2exm/ZIP 5.04 5.50 5.19 5.24 4.11
2fvd/LIA 6.51 6.65 6.23 6.46 8.52
2i6b/89I 6.39 6.79 5.65 6.28 7.17
2ity/IRE 6.07 6.22 5.79 6.03 7.27
2j6m/AEE 6.75 7.78 6.51 7.01 7.96
2pl0/STI 8.39 8.78 7.85 8.34 7.21
2qhm/7CS 5.93 6.00 5.62 5.85 6.18
2xnb/Y8L 10.30 10.67 9.22 10.06 6.83
2zkj/ADP 5.99 6.22 5.83 6.01 5.48
3d2r/ADP 5.92 6.14 5.76 5.94 5.48
3e64/5B3 6.74 7.61 6.64 7.00 7.11
3feg/AMP 5.04 5.10 4.85 5.00 4.35
3g0e/B49 6.75 6.83 6.44 6.67 7.70
3g0f/B49 6.53 6.68 6.24 6.48 7.66
3g15/HC6 7.04 7.43 6.14 6.87 7.00
3gfw/S22 6.80 7.74 6.52 7.02 7.57
3hec/STI 8.19 8.58 7.73 8.16 4.47
3heg/BAX 7.69 8.12 7.29 7.70 6.74
3huc/G97 7.37 7.63 6.65 7.22 5.99
3hv7/1AU 8.65 8.87 8.29 8.60 7.92
3jvs/AGY 6.71 7.45 6.58 6.91 6.54
3l8x/N4D 7.18 7.53 6.96 7.22 7.85
3lhj/LHJ 8.19 8.40 7.64 8.08 9.51
3new/3NE 7.08 7.16 6.32 6.85 5.00
3nga/3NG 7.38 7.72 6.59 7.23 8.00
3nyn/SGV 5.52 5.74 5.24 5.50 6.00
Table 4.8: Name of Kinase data set used in training set
PDB /Ligand ID Name
1b38/ATP Cell Division Protein Kinase 2/Adenosine Triphosphate
1b39/ATP Cell Division Protein Kinase 2/Adenosine Triphosphate
1e1v/CMG Cyclin Dependent Protein Kinase/Cyclo Hexyl methyl Guanine
1e1x/NW1 Cyclin Dependent Protein Kinase/Inhibitor NU6027
1h1p/CMG Cell Division Protein Kinase 2/Inhibitor NU2058
1h1s/4SP Cell Division Protein Kinase 2/Inhibitor NU206102
1jsv/U55 Cell Division Protein Kinase 2/Benzenesulfonamide
1kv1/BMU p38 MAP kinase/Inhibitor 1
1kv2/B96 P38 MAP Kinase/BIRB796
1pf8/SU9 Cell Division Protein Kinase 2/SU9516
1pxm/CK5 Cell Division protein kinase 2/inhibitor 3
1pxn/CK6 Cell Division protein kinase 2/inhibitor 4
1pxo/CK7 Cell Division protein Kinase 2/Inhibitor
1pxp/CK8 Cell Division protein Kinase 2/Inhibitor
1q4l/679 Glycogen Synthase kinase-3 beta/Inhibitor I-5
Continued. . .
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PDB /Ligand ID Name
1y8o/ADP Crystal structure of the PDK3-L2 complex/Adenosine Diphosphate
2c6o/4SP Cell Division Protein kinase 2/Inhibitor
2clx/F18 Cell Division Protein kinase 2/CAN508
2exm/ZIP Human CDK2 in complex with isopenteny ladenine
2fvd/LIA Cyclin dependent kinase 2 (CDK2)/inhibitor
2i6b/89I Adenosine kinase/Inhibitor
2ity/IRE Epidermal Growth factor Receptor(EGFR)/IRESSA
2j6m/AEE Epidermal Growth factor Receptor(EGFR)/AEE788
2pl0/STI LCK bound to imatinib
2qhm/7CS Crystal stucture of check I in complex with Inhibitor 2a
2xnb/Y8L Crystal stucture of check I in complex with Inhibitor 2a
2zkj/ADP Crystal stucture of Human PDK4-ADP complex
3d2r/ADP Kinase Isozyme 4 in complex with ADP
3e64/5B3 ‘tyrosine-proteine kinase Jack2 /Inhibitors
3feg/AMP Choline/Ethanolamine Kinase/Adenosine Monophosphate
3g0e/B49 Mast/Setm cell growth factor receptor/Sunitinib
3g0f/B49 Mast/Setm cell growth factor receptor/Sunitinib
3g15/HC6 Choline kinase alpha/Hemicholinium
3gfw/S22 Dual specificity protein kinase TTK/Pyrolo-pyridin ligand
3hec/STI P38 in complex with Imatinib
3heg/BAX P38 in complex with Sorafenib
3huc/G97 Human P38 Kinase in complex with RL40
3hv7/1AU Human P38 kinase in complex with RL38
3jvs/AGY Serine/Threnonine-protein kinase chk1
3l8x/N4D Mitogen activated protein kinase 14/inhibitor
3lhj/LHJ Mitogen activated protein kinase 14/pyrazolo pyridinone Inhibitor
3new/3NE P38-alpha complexed with compound 10
3nga/3NG Casein Kinase II subunit alpha in complexe with Cx-4945
3nyn/SGV G protein-couple receptor kinase 6 in complex sangivamycin
To do this we assigned a weighting to individual terms and following this, we re-compute X-Score and
test the output against real experimental data to examine the robustness of the weighting used.
First we repeated the same calculation as we did in above here and Table (4.1) gives the analysis of
variance summary.
Table 4.9: Analysis of variance for the kinase data set
Source of variation Degrees of Freedom (df) Sum of Squares (SS) MSreg
Due to regression 1 12.19212 12.19212
About Regression 42 37.07508 s2 = 0.862211
Total, corrected 43 49.2675 -
And R2 statistics is given by





The fitted regression equation for this case is then given by the equation Ŷ = 2.463591 + 0.643372X
which explain only 24.74% of the total variation in the kinase data set about the average Ȳ . In other
word the proportion of data which is not explained by the fitted regression line equation is 75.25%. This
is a large proportion of data.
4.3.1 Standard Deviation of the Gradient : Confidence interval for β1
Before testing the sensitivity of X-Score, we computed the standard deviation of the gradient of our
fitted regression line.
From equation (4.13) we know that
b1 =
∑
(Xi − X̄)(Yi − Ȳ )∑
(Xi − X̄)2
(4.49)





(Xi − X̄) = 0, the gradient b1 becomes
b1 =
∑
(Xi − Ȳ )∑
(Xi − X̄)2
(4.50)

















If σ is unknown and we use the estimates in its place, assuming the model is correct, the estimated




}1/2 = sS2XX (4.53)
The estimated standard deviation is the standard error, se.
Confidence interval for β1 We assign 100(1− α)% confidence limits for β1 by calculating
b1 ±
t(n− 2, 1− 12α)s{∑
(Xi − X̄)2
}1/2 (4.54)
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Where t(n− 2, 1− 1
2
α) is the 100(1− α) percentage point of a t-distribution, with (n− 2) degrees of
freedom.
















est.V ar(b1) = 0.1045636








0.217599 6 β1 6 1.069145
The true value of β1 lies in interval (0.217599 to 1.069145), and this calculation is made with 95%
confidence. Since the goodness of fit decreases as the gradient increases we restricted our confidence
interval to (0.217599 to 1)
Test of Null Hypothesis We tested the null hypothesis that the true β1 is zero, or that there is no
straight line sloping relationship between computed score (Y ) and experimental score (X).
H0 : β1 = 0 H1 : β1 6= 0 (4.55)
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where r is the r-value or the correlation coefficient (computed here as the square root of the coefficient











since | t |= 3.716453 is greater that the critical value of t(42 , 0.975) = 2.0189, H0 : β = 0 is rejected.
We therefore reject the idea that a linear relationship between the computed (Y) values and the observed
values does not exist.
Sensitivity of the Hydrogen Bonding term once we had compute the standard deviation of the
gradient β1 and the confidence interval where the true value of β1 lies we were now ready to investigate
the effect of assigning different weighting to the individual terms on X-Score performance. Following
this, we re-computed the X-Score pKd and tested the output against experimental data to examine the
robustness of weighting used. We will begin by adjusting the weight of the hydrogen bonding term. We
know that the true value of the gradient β1 lies in the interval
0.217599 6 β1 6 1
During the calculation, we dropped the value of the gradient that is outside of the limits interval and for
those in the interval we considered only those for which the p− value ≤ 0.025. Table 4.9 gives all the
Gradient, intercept, r-value, P-value and the standard error when the coefficient of the hydrogen bonding
term undergoes small perturbation in equations ((3.1), (3.2), (3.3). The coefficient were generated by
letting the weight of each term float with a small change of 0.001.
By graphing the data from the Table 4.11 we have the figure below.
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Figure 4.2: Shows a plot of the gradient vs the coefficient for the data in Table 4.11
The optimal value of the gradient is reached when the coefficients are respectively CHB1 = 0.053,
CHB1 = 0.094, CHB1 = 0.069. These are default value from X-Score which also yield the optimal
value of the r-value (r-value is the square root of R2). The r-value is then equal to 0.498092 or using
R2 statistics, 0.248095. Table 4.11 is organized in descending order with respect to the gradient. We
observe in the graph and Table 4.11 that the gradients decrease when the coefficients increase.
We also show in Figure 4.3, the graph of gradient vs coefficient for both increased and decreased
coefficients. We noticed that even when we decrease the coefficient the gradient did not improve much
but a slight improvement of the R2 statistics is achieved.
The table below gives the optimal value reach by the gradient and r − value while we decrease the
coefficient of the hydrogen bonding term.
Table 4.10: Linear regression : statistics summary 1
HBP HBM HBS Gradient intercept r-value p-value stderr
-0.117000 -0.076000 -0.101000 0.609975 2.894121 0.523389 0.000267 0.153232
0.009000 0.050000 0.025000 0.648616 2.484863 0.510719 0.000397 0.168481
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Figure 4.3: Plot of gradient vs coefficient for the hydrogen bonding.
X-Score sensitivity to change in the weighting of Van der Waal Term In the same way we then
tested the sensitivity of X-Score to the perturbation of the Van der Waal term coefficient. Doing as
above we obtain the gradient, intercept and r-value as in Table 4.11. The highest optimal value of the
gradient is attained when the coefficients decrease down to HBP = HBM = HBS = 0.002 in the
Van der Waal term coefficient in equations 3.1, (3.2) and (3.3) for which the gradient is 0.923038. The
highest score of R2 is reached where the gradient is at its optimal value which is 0.261734.
Table 4.11: Sensitivity of gradient to the Van der Waal term
HBP HBM HBS Gradient intercept r − value p− value std− err
0.004000 0.004000 0.004000 0.643372 2.463591 0.498092 0.000580 0.172826
0.005000 0.005000 0.005000 0.551103 2.750216 0.490889 0.000716 0.150923
0.006000 0.006000 0.006000 0.479989 2.980592 0.484305 0.000865 0.133797
0.007000 0.007000 0.007000 0.422544 3.180165 0.477422 0.001049 0.119998
0.008000 0.008000 0.008000 0.377815 3.333343 0.472623 0.001197 0.108704
0.009000 0.009000 0.009000 0.340523 3.468087 0.467705 0.001368 0.099299
0.010000 0.010000 0.010000 0.309522 3.582772 0.463088 0.001548 0.091409
0.011000 0.011000 0.011000 0.283596 3.679462 0.459544 0.001701 0.084574
0.012000 0.012000 0.012000 0.261556 3.762433 0.456139 0.001859 0.078739
0.013000 0.013000 0.013000 0.242800 3.832550 0.453452 0.001993 0.073639
0.014000 0.014000 0.014000 0.226214 3.897293 0.450702 0.002139 0.069135
0.003000 0.003000 0.003000 0.766708 2.098764 0.506702 0.000449 0.201289
0.002000 0.002000 0.002000 0.923038 1.701471 0.511600 0.000386 0.239206
Figure 4.4 shows a plot of the gradient vs the coefficient
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Figure 4.4: Plot of gradient vs coefficients with van der Waal Term
X-Score’s sensitivity to changes in the weighting of the hydrophobic terms The results obtained
when we perturbed the coefficient of the hydrophobic terms are shown in Table 4.12.
From Table 4.12 we see that the highest gradient value of 0, 65 is reached when we use the default
coefficients (HP = 0, 011HM = 0, 395 and HS = 0, 004). But interestingly the correlation coefficient
attained the optimal value of 0.553012 (or R2 = 30.58% ) when the coefficients were HP = 0, 42HM =
0, 425 and HS = 0, 035 compared to r-value of 0, 497543 (or R2 = 24.75%) for the default value. This
suggest that when the gradient decrease from 0.650051 to 0.305819 the proportion of data explained
by the fitting line increases by approximately 5%.
Table 4.12: Sensitivity of the gradient after perturbation of the
Hydrophobic term coefficient
HP HM HS Gradient Intercept r-value p-value std-err
0,042 0,425 0,035 0,305819 3,945552 0,553012 0,000099 0,071095
0,037 0,42 0,03 0,339931 3,767189 0,552982 0,000099 0,079032
0,04 0,423 0,033 0,318621 3,878413 0,552921 0,000099 0,074089
0,039 0,422 0,032 0,325497 3,842707 0,552899 0,000099 0,075692
0,035 0,418 0,028 0,355348 3,688089 0,552809 0,0001 0,082653
0,038 0,421 0,031 0,33233 3,807612 0,552795 0,0001 0,077302
0,036 0,419 0,029 0,347415 3,729346 0,552776 0,0001 0,080815
0,041 0,424 0,034 0,311976 3,913924 0,552748 0,0001 0,072576
0,043 0,426 0,036 0,299668 3,978193 0,552712 0,0001 0,06972
0,044 0,427 0,037 0,293866 4,008486 0,552637 0,0001 0,068383
0,034 0,417 0,027 0,363649 3,645759 0,552592 0,0001 0,084632
0,033 0,416 0,026 0,37228 3,601466 0,55246 0,000101 0,08667
0,045 0,428 0,038 0,288206 4,038694 0,55246 0,000101 0,067097
0,047 0,43 0,04 0,277519 4,095405 0,55232 0,000101 0,064633
0,032 0,415 0,025 0,381169 3,556653 0,552125 0,000102 0,088817
Continued. . .
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HP HM HS Gradient Intercept r-value p-value std-err
0,046 0,429 0,039 0,282577 4,069259 0,552118 0,000102 0,065845
0,031 0,414 0,024 0,390707 3,507406 0,55205 0,000102 0,091058
0,049 0,432 0,042 0,267459 4,149049 0,551922 0,000103 0,062354
0,048 0,431 0,041 0,27222 4,124602 0,551754 0,000103 0,063492
0,05 0,433 0,043 0,262586 4,175698 0,551615 0,000104 0,061267
0,051 0,434 0,044 0,258057 4,199578 0,551598 0,000104 0,060213
0,03 0,413 0,023 0,400097 3,461381 0,551542 0,000104 0,093369
0,052 0,435 0,045 0,253569 4,224007 0,551308 0,000105 0,059211
0,053 0,436 0,046 0,249255 4,247345 0,551212 0,000105 0,058218
0,054 0,437 0,047 0,245054 4,270113 0,550953 0,000106 0,057275
0,029 0,412 0,022 0,410026 3,412269 0,550889 0,000107 0,09585
0,055 0,438 0,048 0,241078 4,291505 0,550749 0,000107 0,056376
0,056 0,439 0,049 0,237188 4,312262 0,550681 0,000107 0,055476
0,028 0,411 0,021 0,42084 3,357563 0,550525 0,000108 0,098471
0,057 0,44 0,05 0,233335 4,333488 0,550438 0,000108 0,05461
0,059 0,442 0,052 0,22616 4,371841 0,550253 0,000109 0,052956
0,058 0,441 0,051 0,229625 4,353613 0,550207 0,000109 0,053774
0,06 0,443 0,053 0,222514 4,392677 0,549717 0,000111 0,052175
0,027 0,41 0,02 0,431393 3,306921 0,549562 0,000112 0,101194
0,061 0,444 0,054 0,219137 4,411094 0,549546 0,000112 0,051406
0,026 0,409 0,019 0,443153 3,24817 0,549344 0,000113 0,104011
0,025 0,408 0,018 0,454293 3,19602 0,547705 0,000119 0,107083
0,024 0,407 0,017 0,466706 3,135936 0,546782 0,000123 0,110274
0,023 0,406 0,016 0,479538 3,074736 0,545307 0,000129 0,113743
0,022 0,405 0,015 0,492764 3,012612 0,544011 0,000135 0,117276
0,021 0,404 0,014 0,506347 2,949591 0,542229 0,000144 0,121071
0,02 0,403 0,013 0,520356 2,886161 0,540359 0,000153 0,12503
0,019 0,402 0,012 0,534194 2,825932 0,537369 0,000169 0,129362
0,018 0,401 0,011 0,549793 2,755425 0,535239 0,000181 0,133884
0,017 0,4 0,01 0,564366 2,694261 0,531516 0,000205 0,13878
0,016 0,399 0,009 0,579132 2,634062 0,527322 0,000235 0,143988
0,015 0,398 0,008 0,595069 2,568226 0,523641 0,000265 0,149389
0,014 0,397 0,007 0,609569 2,515451 0,518358 0,000313 0,155173
0,013 0,396 0,006 0,623715 2,4665 0,512637 0,000374 0,161193
0,012 0,395 0,005 0,637446 2,423966 0,505592 0,000464 0,167847
0,011 0,394 0,004 0,650051 2,390256 0,497543 0,00059 0,174876
X-Score’s sensitivity to change in the weighting of the rotor term The result obtained when we
perturbed the coefficient of the rotor term is shown in Figure 4.6.
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Figure 4.5: Plot of gradient vs coefficients for the hydrophobic terms
4.4 Re-parameterization of X-score
Improving a scoring function can be done either by adding a new term or just by re-parametrising the
existing model to fit the users needs. As our primary protein family is the kinase protein family, our aim
was to re-parameterised X-Score so that it can be used for this specific protein family.
As hydrogen bonding play a crucial role during the binding process, we split this term into two part :
with one term for charged atoms and an another term for uncharged atoms.
Table 4.13 shows the charged amino acids that we have taken into account for the re-parametrisation
process.
4.4.1 Ligands structures
Figures (4.7) ,(4.8) and (4.9) are ligand structures of adenosine triphosphate, adenosine diphosphate
and imatinib bound to CDK2. The interactions shown in each figures are those mediated by hydrogen
bonds and by hydrophobic contacts. Hydrogen bonds are indicated by dashed lines between the atoms
involved while hydrophobic contact are represented by an arc with spaces radiating towards the ligands
atoms they contact. The contacted atoms are shown with spokes radiating back [RCSB Protein Data
Table 4.13: Charged amino acids
Amino acid ID Chemical properties Physical propeties Side chains Name
Asp Acidic Polar (charged) OD1/OD2 Aspartic Acid D
Glu Acidic Polar (charged) OE1/OE2 Glutamic Acid E
Lys Basic Polar (positive charged) NE Lysine K
Arg Basic Polar (positive charged) NE/NH1/NH2 Arginine R
His Basic Polar (positive charged) NE Histidine H
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Figure 4.6: Plot of gradient vs coefficients for the rotor terms
Bank].
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Figure 4.7: Ligand : structure of adenosine triphosphate ATP bound to CDK2
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Figure 4.8: Ligand : structure of adenosine diphosphate (ADP) bound to CDK2
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4.5 Re-pararameterisation model
We recall Equations (3.1),(3.2) and (3.3) each have four parameters namely the Van der Waal (VDW),
hydrogen bonding (HB) and hydrophobic pair (HP)/ hydrophobic match (HM)/hydrophobic surface
(HS). In our model we are going to break the hydrogen bonding into two terms. one term will be for
charged amino acid side chains and the other term will be for the uncharged amino acid side chains.
If we denote for the hydrogen bonding for charged atoms by H − Bondc and for uncharged atoms
H −Bondu, the equations 3.1), (3.2) and (3.3) can now be written as
HPScore = C0,1 + CV DW,1 × (V DW ) + CHB,11 × (H −Bondc)
+ CHB,12 × (H −Bondu) + CHP × (HP ) + CR,1 × (Rotor)
(4.57)
HMScore = C0,2 + CV DW,2 × (V DW ) + CHB,21 × (H −Bondc)
+ CHB,22 × (H −Bondu) + CHM × (HM) + CR,2 × (Rotor)
(4.58)
HSScore = C0,3 + CV DW,3 × (V DW ) + CHB,31 × (H −Bond)
+ CHB,32 × (H −Bondu) + CHS × (HS) + CR,3 × (Rotor)
(4.59)
Where coefficients C0,1; CV DW,1, CHB,11, CHB,12, CHP , CR,1 in HPScore, C0,2, CV DW,2 , CHB,21,
CHB,22, CHM , CR,2 for the HMScore, C0,3, CV DW,3, CHB,31 , CHB,32, CHS , CR,3 for the HSScore
can be found by multiple regression.
4.5.1 Least Square Regression
We made use of R software to compute all the coefficients above by multiple linear regression.
Hydrophobic pair based scoring function A summary of the results for the hydrophobic pair
based-scoring function are shown in Table 4.14.
R gives more than one value for the coefficients of the uncharged terms but the coefficients for which
the significance code was greater than 0.05 were discarded as they are not statistically significant. For
those statistically significant we considered only the one that has the smallest P − value i.e CHBu,14.0.
Hydrophobic match based scoring function A summary of the results for the hydrophobic match
based-scoring function are shown in Table (4.15).
As for Hydrophobic pair the regression for Hydrophobic match yield multiple value for the uncharged
term coefficient and the most significant one has a P − value of 0.000524 i.e CHBu,24.0. This shows
that the constant or intercept of our regression is not statistically significant as the P −value is greater
than 0.05.
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Table 4.14: coefficients for Equation (4.57)
Coefficients Estimates Std Error t value P-value Significance codes
C0,1 0.0839528 0.0410622 2.045 0.041134 0.05
CV DW,1 0.0045956 0.0001954 23.513 < 2e-16 0.001
CHBc,11 0.0671145 0.0059993 11.187 < 2e-16 0.001
CHBu,128 0.1604596 0.0577827 2.777 0.005578 0.01
CHBu,12.0 0.0345801 0.0408915 0.846 0.397925 1
CHBu,12.1 0.0291940 0.0441360 0.661 0.508455 1
CHBu,12.2 0.0721876 0.0577837 1.249 0.211825 1
CHBu,12.3 0.0454549 0.0456834 0.995 0.319951 1
CHBu,12.4 0.0490832 0.0500597 0.980 0.327053 1
CHBu,12.5 0.0715533 0.0500415 1.430 0.153029 1
CHBu,12.6 0.1433458 0.0577939 2.480 0.013273 0.05
CHBu,12.7 0.0794044 0.0447587 1.774 0.076324 0.1
CHBu,12.8 0.0979413 0.0577903 1.695 0.090395 0.1
CHBu,12.9 0.0919027 0.0500444 1.836 0.066559 0.1
CHBu,13.0 0.1086949 0.0418279 2.599 0.009482 0.01
CHBu,13.7 0.1610293 0.0577846 2.787 0.005414 0.01
CHBu,13.8 0.1658454 0.0578028 2.869 0.004193 0.01
CHBu,14.0 0.1742004 0.0500434 3.481 0.000519 0.001
CHP 0.0095084 0.0002867 33.170 < 2e-16 0.001
CR,1 -0,0839061 0.0052379 -16,019 < 2e-16 0.001
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Table 4.15: coefficients for Equation (4.58)
Coefficients Estimates Std Error t value P-value Significance codes
C0,2 0.070672 0.040734 1.735 0.083024 0.1
CV DW,2 0.005231 0.000190 27.530 < 2e-16 0.001
CHBc,21 0.066979 0.005952 11.254 < 2e-16 0.001
CHBu,228 0.160523 0.057333 2.800 0.005200 0.01
CHBu,22.0 0.036499 0.040572 0.900 0.368512 1
CHBu,22.1 0.027396 0.043792 0.626 0.531711 1
CHBu,22.2 0.071107 0.057333 1.240 0.215145 1
CHBu,22.3 0.046901 0.045327 1.035 0.301028 1
CHBu,22.4 0.048494 0.049670 0.976 0.329110 1
CHBu,22.5 0.071077 0.049652 1.432 0.152562 1
CHBu,22.6 0.139660 0.057343 2.436 0.015025 0.05
CHBu,22.7 0.078769 0.044410 1.774 0.076387 0.1
CHBu,22.8 0.094891 0.057340 1.655 0.098225 0.1
CHBu,22.9 0.090092 0.049654 1.814 0.069886 0.1
CHBu,23.0 0.106329 0.041502 2.562 0.010535 0.05
CHBu,23.7 0.162554 0.057334 2.835 0.004662 0.01
CHBu,23.8 0.170802 0.057352 2.978 0.002962 0.01
CHBu,24.0 0.172707 0.049653 3.478 0.000524 0.001
CHM 0.267259 0.007932 33.696 < 2e-16 0.001
CR,2 -0.085362 0.005189 -16.451 < 2e-16 0.001
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Table 4.16: coefficients for Equation (4.59)
Coefficients Estimates Std Error t value P-value Significance codes
C0,3 0.0694501 0.0414868 1.674 0.094403 0.1
CV DW,3 0.0052895 0.0001933 27.359 < 2e-16 0.001
CHB,31 0.0627287 0.0060501 10.368 < 2e-16 0.001
CHBu,328 0.1605290 0.0583923 2.749 0.006071 0.01
CHBu,32.0 0.0415294 0.0413190 1.005 0.315069 1
CHBu,32.1 0.0273010 0.0446015 0.612 0.540588 1
CHBu,32.2 0.0710079 0.0583932 1.216 0.224228 1
CHBu,32.3 0.0470336 0.0461652 1.019 0.308513 1
CHBu,32.4 0.0491235 0.0505878 0.971 0.331729 1
CHBu,32.5 0.0710329 0.0505694 1.405 0.160398 1
CHBu,32.6 0.1393211 0.0584030 2.386 0.017220 0.05
CHBu,32.7 0.0787105 0.0452309 1.740 0.082098 0.1
CHBu,32.8 0.0946105 0.0583997 1.620 0.105501 1
CHBu,32.9 0.0899250 0.0505722 1.778 0.075649 0.1
CHBu,33.0 0.1063132 0.0422690 2.515 0.012036 0.05
CHBu,33.7 0.1626947 0.0583941 2.786 0.005423 0.01
CHBu,33.8 0.1712579 0.0584118 2.932 0.003437 0.01
CHBu,34.0 0.1725697 0.0505712 3.412 0.000667 0.001
CHS 0.0031169 0.0000960 32.466 < 2e-16 0.001
CR,3 -0.0882309 0.0052737 -16.731 < 2e-16 0.001
Section 4.5. Re-pararameterisation model Page 70
Figure 4.9: Ligand : structure of Imatinib or STI bound to CDK2
Hydrophobic surface based scoring function The values for the hydrophobic surface term coeffi-
cients for equation (4.59) are shown in Table 4.16.
4.5.2 Statistical analysis
A statistical analysis of the three scoring functions is shown in Table 4.17
Table 4.17 shows that both R and adjusted R-squared are greater than 0.70 meaning that more than
70% of our data is explained by the multiple regression model. This is a much higher proportion of the
data accounted for by than the original X-score scoring functions. F-statistic help us to validate the
Table 4.17: Statistical summary
Statistics Hydrophobic Pair Hydrophobic Match Hydrophobic Surface
Multiple R-squared 0.7234 0.7277 0.7175
Adjusted R-squared 0.7187 0.7231 0.7128
F-statistic 155.1 158.5 150.7
Residual standard error 0.04086 0.04054 0.04129
P-value < 2.2e− 16 < 2.2e− 16 < 2.2e− 16
degrees of freedom (DF) 1127 1127 1127
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Table 4.18: Test data
Complexes Description Experimental pKd X-Score pKd
2J6M/AEE EGFR/AEE788 7.56 6.95
2JIU/AEE EGFR/AEE788 7.56 7.18
2ITT/AEE EGFR(L858R mutation)/AEE788 7.73 7.16
2ITP/AEE EGFR(G719S mutation)/AEE788 7.95 7.17
1M17/AQ4 EGFR/Erlotinib 8.80 5.75
2ITY/IRE EGFR/Iressa 6.91 5.91
2ITO/IRE EGFR/Iressa 6.91 6.02
2ITZ/IRE EGFR/Iressa 7.96 6.06
2ITU/STU EGFR(L858R)/Staurosporine 7.15 6.34
2ITW/STU EGFR/Staurosporine 7.15 6.32
2ITQ/STU EGFR(G719S )/Staurosporine 7.15 6.42
1XKK/FMM EGFR/Quinazoline inhibitor 8.07 8.07
model as the calculated value show here is far greater than the critical value of 19 and 1127 degrees of
freedom.
4.6 Prediction
In this section we test our re-parameterised X-Score model against 12 Epidermal growth factor receptor
(EGFR) to see how well it performs compared to the original X-Score. The Table 4.18 shows all the data
used for calculation. The Figure 4.10 shows the scatter plot and correlation between the experimental
and calculated pKd values of 12 EGFR complexes in the test data set.
The computation of the regression line from the data in Table 4.18 yield the equation
Y = 5.4683 + 0.1603X (4.60)
Where Y denote the X-Score predicted pKd while represents X the observed or experimental pKd and
the coefficient of determination R2 = 0.01653 showing a poor goodness of fit (i.e only 1.65 of our
data is explained by the regression line) the p-value here is 0.6505. Based on this high p-value at the
level of 95% confidence interval, points to the fact that the correlation between the experimental pKd
and the X-Score pKd for the test data occurred by chance. This is understandable as we emphasize
in Chapters 2 and 3 that X-Score is an empirical scoring function as such it is size dependent. The
test data used here consist merely of 12 sets of data. An other reason for this poor performance of
X-Score on epidermal growth factor receptor is that X-Score failed to capture the energetic penalty due
to the effect of mutation (e.g on the enzyme). We will suggest some path of future investigation on
this matter in the next section.
The Table 4.19 shows the experimental pKd, the X-Score pKd and our model pKd, i.e the weighted
Scoring function pKd. To compute the pKd in our model we make use of the equations (4.57), (4.58)
and (4.59) where in the Hydrogen bonding we distinguish between the charged and uncharged terms.
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Figure 4.10: Correlation between the experimental and X-Score pKd values of 12 EGFR complexes in
the test set.
Table 4.19: pKd for Weighted Scoring function vs Experimental pKd and X-Score pKd
PDB/Ligand ID Experimental pKd X-Score pKd Re-parametrised X-Score pKd
2J6M/AEE 7.56 6.95 7.32
2JIU/AEE 7.56 7.18 7.66
2ITT/AEE 7.73 7.16 7.58
2ITP/AEE 7.95 7.17 7.62
2ITY/IRE 6.91 5.91 6.36
2ITO/IRE 6.91 6.02 6.52
2ITZ/IRE 7,96 6.06 6.53
2ITU/STU 7.15 6.34 6.69
2ITW/STU 7.15 6.42 6.74
2ITQ/STU 7.15 7.16 7.77
1M17/AQ4 8.80 5.75 7.27
1XKK/FMM 8.07 8.07 7.79
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The data in Table 4.19 yield the equation
Y = 2.8834 + 0.5748X (4.61)
as the regression fitting line between the experimental pKd and the computed pKd from the weighted
scoring function; the coefficient of determination R2 = 0.2102696, suggesting that the goodness of fit
is now 21% compared to 1.65% obtained by X-Score. In our model the p-value is 0.1338 even though
this value indicates that the result is not statistically significant at the level of 95% confidence interval
but the trend has improved. Figure 4.11 shows the correlation between the experimental and weighted
pKd for 12 EGFR complexes in the test data set.
Since all the above tests resulted in non statistically significant correlation, we went further to test
whether the difference in the correlation is statistically significant, and we found that the probability
that there is no difference between the two correlations of determination is 0.00003 meaning that it is
unlikely that this difference is due to chance, even though the re-parametrised coefficients were obtained
for analysis of ligand bound structures of different kinase, CDK2. This appears to bode well for the
future applicability of our heuristic approach.
4.7 Future work
4.7.1 Effect of mutation on protein structure
When calculating pKd values, X-Score only consider the ligand-bound complex and then assumes a
fixed average relationship between number of atomic interaction and free energy of binding. Thus, if a
mutation affects the stability of the free and ligand-bound protein equally, X-Score should compute a
pKd value equally well for the mutant protein, but will not do so if the stability effect is differential on
free and ligand-bound protein. However, it is possible that such differential effects may be calculable,
in which case they could be added as additional terms in X-Score.
For example suppose both the wild type (wt) and mutant protein have the same number of pairwise
interaction with ligand but the mutation causes subtle difference in bond length as well as destabilising
the protein structure. This situation can be written by the equation
Eu + L GGGBFGGEf + L GGGBFGGEf .L
Where Eu and Ef is protein or enzyme in unfolded and folded state respectively and L is the ligand.
In Figure 4.12, X-Score can predict the quantity in A which is 4G (formation of wt-ligand complex)
and we can also find the quantity A from experimental data. Protein stability prediction algorithm such
as SDM can predict the quantity in B which is 4G (wt-mutant), i.e the free energy penalty of mutation
on protein stability.
If we could calculate the quantity in C in the Figure 4.12 by similar means (where C equal the free
energy penalty of mutation on the stability of the protein-ligand complex), then we could compute the
quantity in D (where D is the free energy charge on binding of a ligand to the mutant protein).
We now have the following,
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Figure 4.11: Correlation between the experimental and weighted pKd values of 12 EGFR complexes in
the test set.
Figure 4.12: Effect of mutation on protein stability
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A = 4G(wt,true) = calculated from observed Kd,
D = 4G(mut,true) = A + B - C
We can estimate the quantity B from a software like SDM ( = Gwt−Gmut (= 4GSDM ). Then let define
C = 4Gprot +4Gprot.ligand where 4Gprot equal the energy penalty of mutation on protein stability
in the ligand-bound state and 4Gprot.ligand equal the energy penalty of mutation on protein-ligand
interaction.
If we assume that
4Gprot−Ligand = 4G(wt ,X−Score) −4G(mut ,X−Score)
here we use X-Score to tell us about the altered ligand-bound environment in the mutant.
Therefore,













4G(wt , true)−4G(wt ,X−Score)
]





define the specific correction for differential effect of mutation on the protein stability in the
free and ligand-bound forms.
Therefore in principle we just need to calculate the energy penalty of mutation in wild type (wt) ligand-
free protein ( i.e 4GSDM ) and a wt ligand-bound protein ( i.e 4Gprot) and we can then accurately
compute the free energy of binding of the ligand to mutant.
One of the question one can ask is should we really consider all ligand binding free energies relative to
the unfolded protein state ?
In the other hand we know from
4G = −RT LogKa (4.62)
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X-score computes the binding free energy 4G by subtracting the energy in the unbound state from the
bound state meaning when the binding is favourable i.e 4G is negative. This free energy is expressed
by the equation
4G = [GE.L −GE+L] (4.63)
And the energetic penalty of mutation on the stability of the bound complex is given by
44G = 4Gwt −4GMut (4.64)
This equation gives the energetic effect of mutation on the protein and this effect may be neutral or
destabilising if 44G is negative.
Likewise to calculate the effect of a mutation on a ligand bound complex X-Score would need to be
modified by the calculated factor above.
We would need to investigate these 2 hypothesis:
1. Hypothesis 1 : Should we really be considering all ligand binding free energy relatives to the
unfolded protein state ?
2. Hypothesis 2 : is there some approximate proportional relationships between4GSDM and44G?
where 4GSDM represents the energetic penalty between the free wild type and free mutant in the
folded state.
4.7.2 User interface for scoring function for protein family
Another path of investigation will be to develop software tools that allow researchers to select and
modulate the calculated contribution of sets of amino acid residues when applying generalist scoring
functions to drug target from specific protein families. Once this user interface has been developed the
next task will be to test the utility of these tools on the X-score scoring function and EGFR kinase - a
drug target in Non Small Cell Lung Cancer (NSCLC). Any given scoring function would require its own
interface, but once developed, such an interface would be usable for any protein family.
To achieve this a variety of strategies may be applied to select these sets of residues. In the case
of the EGFR kinase protein family a promising initial strategy in the definition of sets of residues to
target for modulation will be structure alignments of variants of the protein, with initial weightings
based thereafter on hydrophobic/hydrophilic character considerations, together with information on
conformational changes that occur on ligand binding. This is a general strategy that may be applied to
any protein family where structures of at least two variants are available.
5. Conclusion
In this thesis we presented a comprehensive review of Scoring functions as a method to compute the
free binding energy between the protein and the drug-like molecules called ligand. We choose X-Score
scoring function as our case study in our re-visitation and re-computation of scoring function. We
addressed the question of sensitivity of X-Score by asking how a coefficient (or weight) of a term in X-
Score vary when the original coefficient value undergoes a small perturbation. We tested the sensitivity
of X-Score on the target training data (data in Table ( 4.7) the X-Score shows some robustness when
the coefficients of hydrogen bonding term undergoes small perturbation the strength of goodness of fit
is inversely proportional to the change coefficients of the terms in X-Score. A notable sensitivity was
observed in the weighting of the hydrophobic terms perturbation. The highest strength of correlation
were obtained when the coefficient of determination was 30.58%. And when the gradient reaches its
optimal value, the coefficient of determination is 24.75% meaning that as the gradient decreases from
0.650051 to 0.305819, the proportion of data explained by the fitting line increased by approximately
5%.
There are many strategies to adopt in order to improve a scoring function and this can be done either
by adding new terms or by re-paramatizing the existing weighted. In our study we adopted the latter by
splitting the hydrogen bonding term into two different terms, we have a term for charged and uncharged
amino acid in the ligand. By doing so we obtained through regressional analysis all the coefficients of all
terms with a multiple R-squared equal to 0.7234 (or 0.7187 for adjusted R-square) for which we deduce
that 71% to 72% our data is explained by the model with a p-value almost zero we can say that this
performance is not due to chance.
The test of the model shows a net improvement compared to original X-Score the result obtained
was statistically meaningful due at level of 95% confidence interval. We constructed our model on an
empirical scoring function as such it remains dependent to the size of the data. So we need more data
set to test and and find out whether the improvement we found from the model is not due to chance.
Finally, we show two paths to further the investigation, in order to improve our heuristic method of
weighted scoring function, one path is to see how the mutation affect the stability of the protein when
computing the free binding energy and the second path is to design a user interface for scoring function
family that will allow researchers to select and modulate the calculated contribution of sets of amino
acid residues when applying commonly used scoring function.
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